Ubiquitin-mediated	O
processing	O
of	O
NF-kappa	B-protein
B	I-protein
transcriptional	B-protein
activator	I-protein
precursor	I-protein
p105	B-protein
.	O

Reconstitution	O
of	O
a	O
cell-free	O
system	O
and	O
identification	O
of	O
the	O
ubiquitin-carrier	B-protein
protein	I-protein
,	O
E2	B-protein
,	O
and	O
a	O
novel	O
ubiquitin-protein	B-protein
ligase	I-protein
,	O
E3	B-protein
,	O
involved	O
in	O
conjugation	O
.	O

In	O
most	O
cases	O
,	O
the	O
transcriptional	B-protein
factor	I-protein
NF-kappa	B-protein
B	I-protein
is	O
a	O
heterodimer	B-protein
consisting	O
of	O
two	O
subunits	O
,	O
p50	B-protein
and	O
p65	B-protein
,	O
which	O
are	O
encoded	O
by	O
two	O
distinct	O
genes	O
of	O
the	O
Rel	B-DNA
family	I-DNA
.	O

p50	B-protein
is	O
translated	O
as	O
a	O
precursor	O
of	O
105	B-protein
kDa	I-protein
.	O

The	O
C-terminal	B-protein
domain	I-protein
of	O
the	O
precursor	O
is	O
rapidly	O
degraded	O
,	O
forming	O
the	O
mature	B-protein
p50	I-protein
subunit	I-protein
consisted	O
of	O
the	O
N-terminal	B-protein
region	I-protein
of	O
the	O
molecule	O
.	O

The	O
mechanism	O
of	O
generation	O
of	O
p50	B-protein
is	O
not	O
known	O
.	O

It	O
has	O
been	O
suggested	O
that	O
the	O
ubiquitin	B-protein
-proteasome	B-protein
system	O
is	O
involved	O
in	O
the	O
process	O
;	O
however	O
,	O
the	O
specific	O
enzymes	B-protein
involved	O
and	O
the	O
mechanism	O
of	O
limited	O
proteolysis	O
,	O
in	O
which	O
half	O
of	O
the	O
molecule	O
is	O
spared	O
,	O
have	O
been	O
obscure	O
.	O

Palombella	O
and	O
colleagues	O
(	O
Palombella	O
,	O
V.J.	O
,	O
Rando	O
,	O
O.J.	O
,	O
Goldberg	O
,	O
A.L.	O
,	O
and	O
Maniatis	O
,	O
T.	O
(	O
1994	O
)	O
Cell	O
78	O
,	O
773-785	O
)	O
have	O
shown	O
that	O
ubiquitin	B-protein
is	O
required	O
for	O
the	O
processing	O
in	O
a	O
cell-free	O
system	O
of	O
a	O
truncated	O
,	O
artificially	O
constructed	O
,	O
60-kDa	B-protein
precursor	I-protein
.	O

They	O
have	O
also	O
shown	O
that	O
proteasome	B-protein
inhibitors	O
block	O
the	O
processing	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
reconstitution	O
of	O
a	O
cell-free	O
processing	O
system	O
and	O
demonstrate	O
directly	O
that	O
:	O
(	O
a	O
)	O
the	O
ubiquitin	B-protein
-proteasome	B-protein
system	O
is	O
involved	O
in	O
processing	O
of	O
the	O
intact	O
p105	B-protein
precursor	O
,	O
(	O
b	O
)	O
conjugation	O
of	O
ubiquitin	B-protein
to	O
the	O
precursor	O
is	O
an	O
essential	O
intermediate	O
step	O
in	O
the	O
processing	O
,	O
(	O
c	O
)	O
the	O
recently	O
discovered	O
novel	O
species	O
of	O
the	O
ubiquitin-carrier	B-protein
protein	I-protein
,	O
E2-F1	B-protein
,	O
that	O
is	O
involved	O
in	O
the	O
conjugation	O
and	O
degradation	O
of	O
p53	B-protein
,	O
is	O
also	O
required	O
for	O
the	O
limited	O
processing	O
of	O
the	O
p105	B-protein
precursor	I-protein
,	O
and	O
(	O
d	O
)	O
a	O
novel	O
,	O
approximately	O
320-kDa	B-protein
species	I-protein
of	O
ubiquitin-protein	B-protein
ligase	I-protein
,	O
is	O
involved	O
in	O
the	O
process	O
.	O

This	O
novel	O
enzyme	O
is	O
distinct	O
from	O
E6-AP	B-protein
,	O
the	O
p53-conjugating	B-protein
ligase	I-protein
,	O
and	O
from	O
E3	B-protein
alpha	I-protein
,	O
the	O
``	B-protein
N-end	I-protein
rule	I-protein
''	I-protein
ligase	I-protein
.	O

THE	NULL
JoUrNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

270	NULL
,	NULL
No	NULL
.	NULL

37	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

21707-21714	NULL
,	NULL
1995	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Ubiquitin-mediated	NULL
Processing	NULL
of	NULL
Transcriptional	NULL
Activator	NULL
Precursor	NULL
p105	NULL
RECONSTITUTION	NULL
OF	NULL
A	NULL
CELL-FREE	NULL
SYSTEM	NULL
AND	NULL
IDENTIFICATION	NULL
OF	NULL
THE	NULL
UBIQUITIN-CARRIER	NULL
PROTEIN	NULL
,	NULL
£2	NULL
,	NULL
AND	NULL
A	NULL
NOVEL	NULL
UBIQUITIN-PROTEIN	NULL
LIGASE	NULL
,	NULL
£3	NULL
,	NULL
INVOLVED	NULL
IN	NULL
CONJUGATION®*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
April	NULL
28	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
June	NULL
22	NULL
,	NULL
1995	NULL
)	NULL
Amir	NULL
Oriant	NULL
,	NULL
Simon	NULL
Whiteside§	NULL
,	NULL
Alain	NULL
Israél§	NULL
,	NULL
Hana	NULL
Stancovski	NULL
$	NULL
,	NULL
Alan	NULL
L.	NULL
Schwartz	NULL
(	NULL
,	NULL
and	NULL
Aaron	NULL
Ciechanovert|	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
the	NULL
Rappaport	NULL
Institute	NULL
for	NULL
Research	NULL
in	NULL
the	NULL
Medical	NULL
Sciences	NULL
,	NULL
Faculty	NULL
of	NULL
Medicine	NULL
,	NULL
Technion-Israel	NULL
Institute	NULL
of	NULL
Technology	NULL
,	NULL
P.	NULL
O	NULL
.	NULL

Box	NULL
9649	NULL
,	NULL
Haifa	NULL
31096	NULL
,	NULL
Israel	NULL
,	NULL
§Unité	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
de	NULL
I'Expression	NULL
Génique	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
25	NULL
rue	NULL
du	NULL
Dr.	NULL
Roux	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
,	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Hematology-Oncology	NULL
,	NULL
Children	NULL
's	NULL
Hospital	NULL
and	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
In	NULL
most	NULL
cases	NULL
,	NULL
the	NULL
transcriptional	NULL
factor	NULL
is	NULL
a	NULL
heterodimer	NULL
consisting	NULL
of	NULL
two	NULL
subunits	NULL
,	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
which	NULL
are	NULL
encoded	NULL
by	NULL
two	NULL
distinct	NULL
genes	NULL
of	NULL
the	NULL
Rel	NULL
fam-ily	NULL
.	NULL

p50	NULL
is	NULL
translated	NULL
as	NULL
a	NULL
precursor	NULL
of	NULL
105	NULL
kDa	NULL
.	NULL

The	NULL
C-terminal	NULL
domain	NULL
of	NULL
the	NULL
precursor	NULL
is	NULL
rapidly	NULL
degraded	NULL
,	NULL
forming	NULL
the	NULL
mature	NULL
p50	NULL
subunit	NULL
consisted	NULL
of	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
molecule	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
generation	NULL
of	NULL
p50	NULL
is	NULL
not	NULL
known	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
ubiquitin-proteasome	NULL
system	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
process	NULL
;	NULL
however	NULL
,	NULL
the	NULL
specific	NULL
enzymes	NULL
involved	NULL
and	NULL
the	NULL
mechanism	NULL
of	NULL
limited	NULL
proteolysis	NULL
,	NULL
in	NULL
which	NULL
half	NULL
of	NULL
the	NULL
molecule	NULL
is	NULL
spared	NULL
,	NULL
have	NULL
been	NULL
obscure	NULL
.	NULL

Palombella	NULL
and	NULL
colleagues	NULL
(	NULL
Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
Rando	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
Goldberg	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
7783-785	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
ubiquitin	NULL
is	NULL
required	NULL
for	NULL
the	NULL
processing	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
of	NULL
a	NULL
truncated	NULL
,	NULL
artificially	NULL
constructed	NULL
,	NULL
60-kDa	NULL
precursor	NULL
.	NULL

They	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
proteasome	NULL
inhibitors	NULL
block	NULL
the	NULL
processing	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
reconstitution	NULL
of	NULL
a	NULL
cell-free	NULL
processing	NULL
system	NULL
and	NULL
demonstrate	NULL
directly	NULL
that	NULL
:	NULL
(	NULL
a	NULL
)	NULL
the	NULL
ubiquitin-proteasome	NULL
system	NULL
is	NULL
involved	NULL
in	NULL
processing	NULL
of	NULL
the	NULL
intact	NULL
p105	NULL
precursor	NULL
,	NULL
(	NULL
b	NULL
)	NULL
conjugation	NULL
of	NULL
ubiquitin	NULL
to	NULL
the	NULL
precursor	NULL
is	NULL
an	NULL
essential	NULL
intermediate	NULL
step	NULL
in	NULL
the	NULL
processing	NULL
,	NULL
(	NULL
c	NULL
)	NULL
the	NULL
recently	NULL
discovered	NULL
novel	NULL
species	NULL
of	NULL
the	NULL
ubiquitin-carrier	NULL
protein	NULL
,	NULL
£2-F1	NULL
,	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
conjugation	NULL
and	NULL
degradation	NULL
of	NULL
p53	NULL
,	NULL
is	NULL
also	NULL
required	NULL
for	NULL
the	NULL
limited	NULL
processing	NULL
of	NULL
the	NULL
p105	NULL
precursor	NULL
,	NULL
and	NULL
(	NULL
d	NULL
)	NULL
a	NULL
novel	NULL
,	NULL
~320-kDa	NULL
species	NULL
of	NULL
ubiquitin-protein	NULL
ligase	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
process	NULL
.	NULL

This	NULL
novel	NULL
enzyme	NULL
is	NULL
distinct	NULL
from	NULL
EG6-AP	NULL
,	NULL
the	NULL
p53-conjugating	NULL
ligase	NULL
,	NULL
and	NULL
from	NULL
E3a	NULL
,	NULL
the	NULL
``	NULL
N-end	NULL
rule	NULL
``	NULL
ligase	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
transcriptional	NULL
activators	NULL
have	NULL
recently	NULL
gained	NULL
considerable	NULL
attention	NULL
because	NULL
of	NULL
their	NULL
unique	NULL
mechanism	NULL
of	NULL
activation	NULL
,	NULL
and	NULL
their	NULL
*	NULL
The	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Council	NULL
for	NULL
Tobacco	NULL
Research-U	NULL
.	NULL

S.	NULL
A.	NULL
,	NULL
Inc.	NULL
,	NULL
the	NULL
German-Israeli	NULL
Foundation	NULL
for	NULL
Scientific	NULL
Research	NULL
and	NULL
Development	NULL
,	NULL
the	NULL
Israeli	NULL
Academy	NULL
of	NULL
Sciences	NULL
and	NULL
Hu-manities	NULL
,	NULL
Monsanto	NULL
,	NULL
Inc.	NULL
,	NULL
the	NULL
Israel	NULL
Cancer	NULL
Research	NULL
Fund	NULL
(	NULL
ICRF	NULL
)	NULL
,	NULL
the	NULL
Foundation	NULL
for	NULL
Promotion	NULL
of	NULL
Research	NULL
in	NULL
the	NULL
Technion	NULL
,	NULL
the	NULL
Henri	NULL
Gutwirth	NULL
Fund	NULL
,	NULL
and	NULL
a	NULL
research	NULL
fund	NULL
administered	NULL
by	NULL
the	NULL
Vice	NULL
President	NULL
of	NULL
the	NULL
Technion	NULL
for	NULL
Research	NULL
(	NULL
to	NULL
A.	NULL
C.	NULL
)	NULL
,	NULL
grants	NULL
from	NULL
ARC	NULL
,	NULL
ANRS	NULL
,	NULL
Ligue	NULL
Nationale	NULL
Francaise	NULL
Contre	NULL
le	NULL
Cancer	NULL
,	NULL
and	NULL
INSERM	NULL
(	NULL
to	NULL
A.	NULL
L.	NULL
)	NULL
,	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
HFSPO	NULL
(	NULL
to	NULL
S.	NULL
W.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
all	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
972-4-295365	NULL
or	NULL
972-4-2958379	NULL
;	NULL
Fax	NULL
:	NULL
972-4-513922	NULL
or	NULL
972-4-552296.	NULL
active	NULL
role	NULL
in	NULL
cytoplasmic-nuclear	NULL
signaling	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
extracellular	NULL
stimuli	NULL
.	NULL

In	NULL
most	NULL
cases	NULL
,	NULL
NF-kB	NULL
is	NULL
a	NULL
heterodimeric	NULL
complex	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
.	NULL

p50	NULL
is	NULL
initially	NULL
synthesized	NULL
as	NULL
an	NULL
inactive	NULL
105-kDa	NULL
precursor	NULL
that	NULL
is	NULL
processed	NULL
to	NULL
the	NULL
mature	NULL
protein	NULL
following	NULL
removal	NULL
of	NULL
the	NULL
C-terminal	NULL
domain	NULL
of	NULL
the	NULL
molecule	NULL
.	NULL

A	NULL
second	NULL
precursor	NULL
molecule	NULL
,	NULL
p100	NULL
,	NULL
gives	NULL
rise	NULL
to	NULL
the	NULL
p52	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
probably	NULL
via	NULL
a	NULL
similar	NULL
mechanism	NULL
.	NULL

The	NULL
heterodimeric	NULL
complex	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
an	NULL
inducible	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
able	NULL
to	NULL
bind	NULL
the	NULL
«	NULL
light	NULL
chain	NULL
enhancer	NULL
(	NULL
1	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
now	NULL
recognized	NULL
to	NULL
be	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
factor	NULL
that	NULL
is	NULL
present	NULL
as	NULL
an	NULL
inactive	NULL
ternary	NULL
complex	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
most	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
ternary	NULL
complex	NULL
,	NULL
a	NULL
third	NULL
inhibitory	NULL
protein	NULL
belonging	NULL
to	NULL
the	NULL
IxB	NULL
family	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
heterodimer	NULL
(	NULL
for	NULL
recent	NULL
reviews	NULL
,	NULL
see	NULL
Refs	NULL
.	NULL

2-4	NULL
)	NULL
.	NULL

A	NULL
wide	NULL
range	NULL
of	NULL
stimuli	NULL
such	NULL
as	NULL
bacterial	NULL
products	NULL
,	NULL
parasites	NULL
,	NULL
viruses	NULL
and	NULL
viral	NULL
products	NULL
,	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
fibroblast	NULL
mitogens	NULL
,	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
,	NULL
physical	NULL
and	NULL
oxidative	NULL
stresses	NULL
,	NULL
and	NULL
drugs	NULL
lead	NULL
to	NULL
accelerated	NULL
processing	NULL
of	NULL
the	NULL
precursor	NULL
,	NULL
degradation	NULL
of	NULL
the	NULL
inhibitor	NULL
,	NULL
and	NULL
consequent	NULL
translocation	NULL
of	NULL
the	NULL
active	NULL
heterodimeric	NULL
factor	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
exerts	NULL
its	NULL
transcriptional	NULL
activity	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Cellular	NULL
target	NULL
genes	NULL
are	NULL
largely	NULL
involved	NULL
in	NULL
the	NULL
acute-phase	NULL
response	NULL
,	NULL
inflammation	NULL
,	NULL
lymphocyte	NULL
activation	NULL
,	NULL
and	NULL
cell	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

These	NULL
genes	NULL
include	NULL
,	NULL
among	NULL
others	NULL
,	NULL
immunoreceptors	NULL
such	NULL
as	NULL
the	NULL
a	NULL
and	NULL
B	NULL
chains	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
,	NULL
major	NULL
histocompatibility	NULL
protein	NULL
class	NULL
I	NULL
and	NULL
II	NULL
molecules	NULL
,	NULL
cell	NULL
adhesion	NULL
molecules	NULL
such	NULL
as	NULL
ELAM-1	NULL
and	NULL
VCAM-1	NULL
,	NULL
cytokines	NULL
,	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
such	NULL
as	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
interleukin-2	NULL
,	NULL
and	NULL
acute	NULL
phase	NULL
proteins	NULL
such	NULL
as	NULL
angiotensinogen	NULL
and	NULL
complement	NULL
factor	NULL
B.	NULL
Interestingly	NULL
,	NULL
it	NULL
also	NULL
affects	NULL
regulation	NULL
of	NULL
transcription	NULL
of	NULL
transcriptional	NULL
activators	NULL
,	NULL
including	NULL
p105	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
IxBa	NULL
(	NULL
2	NULL
,	NULL
5	NULL
)	NULL
.	NULL

The	NULL
physiological	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
recently	NULL
studied	NULL
by	NULL
using	NULL
mice	NULL
that	NULL
lack	NULL
the	NULL
p50	NULL
subunit	NULL
.	NULL

The	NULL
disruption	NULL
leads	NULL
to	NULL
multifocal	NULL
defects	NULL
in	NULL
a	NULL
whole	NULL
array	NULL
of	NULL
immune	NULL
responses	NULL
.	NULL

These	NULL
involve	NULL
,	NULL
for	NULL
example	NULL
,	NULL
inability	NULL
of	NULL
B	NULL
lymphocytes	NULL
to	NULL
respond	NULL
to	NULL
bacterial	NULL
products	NULL
,	NULL
defect	NULL
in	NULL
basal	NULL
and	NULL
specific	NULL
antibody	NULL
production	NULL
,	NULL
and	NULL
high	NULL
susceptibility	NULL
to	NULL
certain	NULL
pathogens	NULL
(	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
,	NULL
p65	NULL
or	NULL
RelB	NULL
for	NULL
example	NULL
,	NULL
display	NULL
a	NULL
similar	NULL
phenotype	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
are	NULL
subjected	NULL
to	NULL
multiple	NULL
regulatory	NULL
influences	NULL
.	NULL

A	NULL
major	NULL
component	NULL
of	NULL
this	NULL
regulation	NULL
involves	NULL
control	NULL
of	NULL
their	NULL
intracellular	NULL
localization	NULL
,	NULL
with	NULL
the	NULL
inactive	NULL
proteins	NULL
maintained	NULL
in	NULL
the	NULL
cytosol	NULL
.	NULL

Regulation	NULL
is	NULL
controlled	NULL
by	NULL
two	NULL
major	NULL
pathways	NULL
:	NULL
(	NULL
i	NULL
)	NULL
control	NULL
of	NULL
p105	NULL
and	NULL
p100	NULL
processing	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
21707	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
21708	NULL
interaction	NULL
of	NULL
the	NULL
p50/p65	NULL
heterodimer	NULL
with	NULL
a	NULL
group	NULL
of	NULL
inhibitor	NULL
molecules	NULL
,	NULL
IxBs	NULL
.	NULL

The	NULL
two	NULL
pathways	NULL
may	NULL
respond	NULL
to	NULL
different	NULL
stimuli	NULL
,	NULL
thus	NULL
providing	NULL
a	NULL
tight	NULL
control	NULL
of	NULL
the	NULL
response	NULL
.	NULL

(	NULL
i	NULL
)	NULL
The	NULL
precursor	NULL
molecules	NULL
p105	NULL
and	NULL
p100	NULL
contain	NULL
in	NULL
their	NULL
N-terminal	NULL
region	NULL
the	NULL
p50	NULL
and	NULL
the	NULL
p52	NULL
moieties	NULL
,	NULL
whereas	NULL
the	NULL
C-terminal	NULL
domain	NULL
contains	NULL
ankyrin	NULL
repeats	NULL
,	NULL
homologous	NULL
to	NULL
I	NULL
«	NULL
B	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
generated	NULL
by	NULL
ATP-dependent	NULL
processing	NULL
of	NULL
p105	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
Ref	NULL
.	NULL

9	NULL
;	NULL
in	NULL
vitro	NULL
,	NULL
the	NULL
researchers	NULL
used	NULL
an	NULL
artificially	NULL
truncated	NULL
form	NULL
of	NULL
p105	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
60	NULL
kDa	NULL
,	NULL
p60	NULL
)	NULL
.	NULL

The	NULL
processing	NULL
is	NULL
regulated	NULL
.	NULL

It	NULL
is	NULL
accel-erated	NULL
,	NULL
for	NULL
example	NULL
,	NULL
after	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
,	NULL
double-stranded	NULL
RNA	NULL
,	NULL
and	NULL
phorbol	NULL
esters	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Recent	NULL
evidence	NULL
suggests	NULL
that	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
involved	NULL
in	NULL
processing	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
,	NULL
p105	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
addition	NULL
of	NULL
ubiquitin	NULL
to	NULL
a	NULL
Fraction	NULL
II	NULL
which	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
protein	NULL
,	NULL
stimulated	NULL
processing	NULL
of	NULL
p60	NULL
to	NULL
p50	NULL
.	NULL

Addition	NULL
of	NULL
ubiquitin-Arg*	NULL
``	NULL
,	NULL
a	NULL
derivative	NULL
of	NULL
ubiquitin	NULL
that	NULL
can	NULL
not	NULL
generate	NULL
polyubiquitin	NULL
chains	NULL
,	NULL
inhibited	NULL
processing	NULL
.	NULL

However	NULL
,	NULL
in	NULL
these	NULL
two	NULL
experiments	NULL
the	NULL
researchers	NULL
have	NULL
not	NULL
demonstrated	NULL
the	NULL
formation	NULL
of	NULL
ubiquitin-p60	NULL
adducts	NULL
,	NULL
the	NULL
essential	NULL
intermediates	NULL
in	NULL
the	NULL
process	NULL
.	NULL

In	NULL
a	NULL
different	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
inhibitors	NULL
of	NULL
the	NULL
20	NULL
S	NULL
proteasome	NULL
complex	NULL
block	NULL
processing	NULL
not	NULL
only	NULL
of	NULL
p60	NULL
in	NULL
vitro	NULL
,	NULL
but	NULL
also	NULL
of	NULL
p105	NULL
in	NULL
intact	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
proteasome	NULL
does	NULL
not	NULL
necessarily	NULL
indicate	NULL
intermediacy	NULL
of	NULL
the	NULL
ubiquitin	NULL
system	NULL
in	NULL
the	NULL
process	NULL
.	NULL

Ornithine	NULL
decarboxylase	NULL
,	NULL
for	NULL
example	NULL
,	NULL
is	NULL
degraded	NULL
in	NULL
a	NULL
proteasome-dependent	NULL
,	NULL
but	NULL
ubiquitin-independent	NULL
,	NULL
process	NULL
(	NULL
13	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
The	NULL
interaction	NULL
with	NULL
the	NULL
inhibitor	NULL
,	NULL
I	NULL
«	NULL
B	NULL
,	NULL
masks	NULL
a	NULL
nuclear	NULL
localization	NULL
signal	NULL
and	NULL
thus	NULL
leads	NULL
to	NULL
retention	NULL
of	NULL
the	NULL
heterodimer	NULL
in	NULL
the	NULL
cytosol	NULL
(	NULL
14	NULL
)	NULL
.	NULL

In	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
extracellular	NULL
stimuli	NULL
,	NULL
I	NULL
«	NULL
B	NULL
is	NULL
rapidly	NULL
degraded	NULL
,	NULL
thus	NULL
exposing	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
and	NULL
allowing	NULL
translocation	NULL
of	NULL
the	NULL
p50/p65	NULL
dimer	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
extracellular	NULL
stimuli	NULL
lead	NULL
to	NULL
phosphorylation	NULL
of	NULL
the	NULL
inhibitor	NULL
,	NULL
but	NULL
that	NULL
this	NULL
modification	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

It	NULL
was	NULL
proposed	NULL
that	NULL
phosphorylation	NULL
signals	NULL
the	NULL
protein	NULL
for	NULL
degradation	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
is	NULL
probably	NULL
degraded	NULL
while	NULL
associated	NULL
as	NULL
a	NULL
complex	NULL
with	NULL
the	NULL
other	NULL
two	NULL
components	NULL
of	NULL
the	NULL
ternary	NULL
complex	NULL
.	NULL

Indeed	NULL
,	NULL
Brown	NULL
and	NULL
colleagues	NULL
(	NULL
19	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
phosphorylation	NULL
of	NULL
Ser	NULL
residues	NULL
32	NULL
or	NULL
36	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
proteolysis	NULL
recognition	NULL
signal	NULL
.	NULL

Furthermore	NULL
,	NULL
inhibitors	NULL
of	NULL
the	NULL
20	NULL
S	NULL
proteasome	NULL
stabilize	NULL
specifically	NULL
the	NULL
phosphorylated	NULL
form	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Recent	NULL
evidence	NULL
from	NULL
our	NULL
laboratories	NULL
indicate	NULL
that	NULL
the	NULL
ubiquitin	NULL
system	NULL
is	NULL
involved	NULL
in	NULL
rapid	NULL
degradation	NULL
of	NULL
the	NULL
stimulation-induced	NULL
phosphorylated	NULL
form	NULL
of	NULL
the	NULL
inhibitor	NULL
.	NULL

The	NULL
unmodified	NULL
form	NULL
is	NULL
not	NULL
recognized	NULL
.	NULL
``	NULL

The	NULL
ubiquitin-dependent	NULL
pathway	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
degradation	NULL
of	NULL
several	NULL
key	NULL
short-lived	NULL
regulatory	NULL
proteins	NULL
(	NULL
reviewed	NULL
recently	NULL
in	NULL
Ref	NULL
.	NULL

21	NULL
)	NULL
.	NULL

Degradation	NULL
of	NULL
a	NULL
protein	NULL
via	NULL
the	NULL
ubiquitin	NULL
pathway	NULL
involves	NULL
two	NULL
distinct	NULL
steps	NULL
,	NULL
both	NULL
requiring	NULL
ATP	NULL
:	NULL
signaling	NULL
of	NULL
the	NULL
protein	NULL
by	NULL
covalent	NULL
attachment	NULL
of	NULL
multiple	NULL
molecules	NULL
of	NULL
ubiquitin	NULL
,	NULL
and	NULL
degradation	NULL
of	NULL
the	NULL
targeted	NULL
protein	NULL
by	NULL
a	NULL
multisubunit	NULL
26	NULL
S	NULL
proteasome	NULL
complex	NULL
.	NULL

Conjugation	NULL
of	NULL
ubiquitin	NULL
proceeds	NULL
via	NULL
a	NULL
three-step	NULL
mechanism	NULL
.	NULL

Initially	NULL
,	NULL
ubiquitin	NULL
is	NULL
activated	NULL
to	NULL
a	NULL
high	NULL
energy	NULL
intermediate	NULL
by	NULL
the	NULL
ubiquitin-activated	NULL
enzyme	NULL
,	NULL
E1	NULL
.	NULL
``	NULL

Following	NULL
activation	NULL
,	NULL
ubiquitin-carrier	NULL
protein	NULL
,	NULL
£2	NULL
,	NULL
transfers	NULL
ubiquitin	NULL
from	NULL
E1	NULL
to	NULL
a	NULL
ubiquitin-protein	NULL
ligase	NULL
,	NULL
£3	NULL
,	NULL
to	NULL
which	NULL
the	NULL
target	NULL
protein	NULL
is	NULL
bound	NULL
.	NULL

E3	NULL
,	NULL
therefore	NULL
,	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
selection	NULL
of	NULL
*	NULL
Y.	NULL
Ben-Neriah	NULL
and	NULL
A.	NULL
Ciechanover	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
E1	NULL
,	NULL
ubiquitin-activating	NULL
enzyme	NULL
;	NULL
£2	NULL
,	NULL
ubiquitin-carrier	NULL
protein	NULL
or	NULL
ubiquitin-conjugating	NULL
enzyme	NULL
;	NULL
£3	NULL
,	NULL
ubiquitin-protein	NULL
ligase	NULL
;	NULL
£6	NULL
,	NULL
human	NULL
papillomavirus	NULL
``	NULL
high	NULL
risk	NULL
``	NULL
£6	NULL
16	NULL
onco-protein	NULL
;	NULL
K6-AP	NULL
,	NULL
E6G-associated	NULL
protein	NULL
;	NULL
ATPyS	NULL
,	NULL
adenosine	NULL
5'-O-	NULL
(	NULL
3-thio-triphosphate	NULL
)	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
MeUb	NULL
,	NULL
reductively	NULL
methylated	NULL
ubiquitin	NULL
;	NULL
NEM	NULL
,	NULL
N-ethylmaleimide	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electro-phoresis	NULL
;	NULL
TEMED	NULL
,	NULL
N	NULL
,	NULL
N	NULL
,	NULL
N	NULL
'	NULL
,	NULL
N	NULL
'	NULL
-tetramethylenediamine	NULL
.	NULL

NF-kB	NULL
Precursor	NULL
Processing	NULL
by	NULL
the	NULL
Ubiquitin	NULL
System	NULL
proteins	NULL
for	NULL
conjugation	NULL
and	NULL
degradation	NULL
.	NULL

The	NULL
multiply	NULL
ubiq-uitinated	NULL
substrate	NULL
is	NULL
specifically	NULL
recognized	NULL
by	NULL
the	NULL
26	NULL
S	NULL
proteasome	NULL
complex	NULL
.	NULL

The	NULL
protein	NULL
moiety	NULL
of	NULL
the	NULL
adduct	NULL
is	NULL
degraded	NULL
with	NULL
the	NULL
release	NULL
of	NULL
free	NULL
and	NULL
reutilizable	NULL
ubiquitin	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Processing	NULL
of	NULL
the	NULL
p105	NULL
precursor	NULL
is	NULL
the	NULL
first	NULL
example	NULL
in	NULL
which	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
involved	NULL
in	NULL
limited	NULL
proteolysis	NULL
and	NULL
not	NULL
in	NULL
complete	NULL
destruction	NULL
of	NULL
its	NULL
protein	NULL
substrates	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
E1	NULL
(	NULL
and	NULL
the	NULL
whole	NULL
ubiquitination	NULL
machinery	NULL
)	NULL
is	NULL
required	NULL
for	NULL
limited	NULL
processing	NULL
of	NULL
antigenic	NULL
proteins	NULL
and	NULL
generation	NULL
of	NULL
antigenic	NULL
peptides	NULL
(	NULL
24	NULL
)	NULL
has	NULL
been	NULL
challenged	NULL
recently	NULL
(	NULL
25	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
the	NULL
C-terminal	NULL
domain	NULL
is	NULL
first	NULL
cleaved	NULL
and	NULL
then	NULL
degraded	NULL
,	NULL
or	NULL
if	NULL
processing	NULL
proceeds	NULL
via	NULL
successive	NULL
removal	NULL
of	NULL
amino	NULL
acid	NULL
residues	NULL
from	NULL
the	NULL
C-terminal	NULL
residue	NULL
of	NULL
p105	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
cleavage	NULL
site	NULL
,	NULL
or	NULL
the	NULL
``	NULL
stop	NULL
``	NULL
signal	NULL
,	NULL
is	NULL
also	NULL
obscure	NULL
.	NULL

Thus	NULL
,	NULL
because	NULL
of	NULL
the	NULL
peculiar	NULL
mechanisms	NULL
involved	NULL
and	NULL
the	NULL
central	NULL
role	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
plays	NULL
in	NULL
many	NULL
basic	NULL
physiological	NULL
and	NULL
pathological	NULL
processes	NULL
,	NULL
dissection	NULL
of	NULL
the	NULL
mechanism	NULL
involved	NULL
in	NULL
ubiquitin	NULL
modification	NULL
and	NULL
processing	NULL
of	NULL
p105	NULL
has	NULL
broad	NULL
biological	NULL
impli-cations	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
enzymatic	NULL
process	NULL
can	NULL
provide	NULL
an	NULL
important	NULL
insight	NULL
into	NULL
the	NULL
regulation	NULL
and	NULL
the	NULL
recognition	NULL
signals	NULL
involved	NULL
.	NULL

Using	NULL
a	NULL
cell-free	NULL
system	NULL
,	NULL
we	NULL
have	NULL
been	NULL
able	NULL
to	NULL
reconstitute	NULL
processing	NULL
of	NULL
the	NULL
intact	NULL
p105	NULL
precursor	NULL
into	NULL
the	NULL
mature	NULL
p50	NULL
protein	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
the	NULL
precursor	NULL
is	NULL
multiply	NULL
ubiq-uitinated	NULL
and	NULL
that	NULL
formation	NULL
of	NULL
the	NULL
high	NULL
molecular	NULL
weight	NULL
conjugates	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
processing	NULL
to	NULL
occur	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
that	NULL
the	NULL
process	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
recently	NULL
described	NULL
ubiquitin-carrier	NULL
protein	NULL
,	NULL
£2-F1	NULL
(	NULL
26	NULL
)	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
degradation	NULL
of	NULL
p53	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
novel	NULL
,	NULL
still	NULL
unidentified	NULL
,	NULL
~320-kDa	NULL
species	NULL
of	NULL
ubiquitin-protein	NULL
ligase	NULL
,	NULL
£3	NULL
,	NULL
appears	NULL
to	NULL
catalyze	NULL
the	NULL
final	NULL
step	NULL
in	NULL
the	NULL
conjugation	NULL
reaction	NULL
,	NULL
transfer	NULL
of	NULL
ubiquitin	NULL
to	NULL
the	NULL
substrate	NULL
.	NULL

The	NULL
ligase	NULL
is	NULL
clearly	NULL
distinct	NULL
from	NULL
E6-AP	NULL
,	NULL
the	NULL
p53-recognizing	NULL
ligase	NULL
,	NULL
and	NULL
from	NULL
E3	NULL
,	NULL
the	NULL
N-end	NULL
rule	NULL
ligase	NULL
.	NULL

However	NULL
,	NULL
like	NULL
E6-AP	NULL
,	NULL
chemical	NULL
modification	NULL
of	NULL
-SH	NULL
groups	NULL
of	NULL
the	NULL
new	NULL
E3	NULL
enzyme	NULL
inhibits	NULL
its	NULL
activity	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-Plasmid	NULL
pT7B105	NULL
contains	NULL
the	NULL
entire	NULL
coding	NULL
sequence	NULL
of	NULL
human	NULL
p105	NULL
fused	NULL
to	NULL
the	NULL
5'-untranslated	NULL
region	NULL
of	NULL
B-globin	NULL
to	NULL
ensure	NULL
efficient	NULL
translation	NULL
in	NULL
vitro	NULL
(	NULL
7	NULL
,	NULL
28	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
subcloned	NULL
into	NULL
pGEM2	NULL
transcription	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
that	NULL
contains	NULL
a	NULL
T7	NULL
promoter	NULL
.	NULL

Vectors	NULL
containing	NULL
E6	NULL
and	NULL
wild	NULL
type	NULL
p53	NULL
cDNAs	NULL
were	NULL
described	NULL
elsewhere	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Na	NULL
``	NULL
°I	NULL
and	NULL
(	NULL
>	NULL
1,200	NULL
Ci/mmol	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
DuPont	NULL
NEN	NULL
.	NULL

Amplify®	NULL
enhancer	NULL
and	NULL
Rainbow	NULL
prestained	NULL
molecular	NULL
weight	NULL
markers	NULL
were	NULL
purchased	NULL
from	NULL
Amersham	NULL
Corp.	NULL
Lysozyme	NULL
,	NULL
ubiquitin	NULL
(	NULL
bovine	NULL
)	NULL
,	NULL
ovalbumin	NULL
,	NULL
DTT	NULL
,	NULL
ATP	NULL
,	NULL
phosphocreatine	NULL
,	NULL
creatine	NULL
kinase	NULL
,	NULL
2-deoxyglucose	NULL
,	NULL
NEM	NULL
,	NULL
sodium	NULL
iodoacetate	NULL
,	NULL
p-hydroxy	NULL
mercuribenzoate	NULL
,	NULL
and	NULL
Tris	NULL
buffer	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Hexoki-nase	NULL
,	NULL
ribonuclease	NULL
A	NULL
(	NULL
RNase	NULL
A	NULL
)	NULL
,	NULL
and	NULL
ATPyS	NULL
were	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
.	NULL

DEAE-cellulose	NULL
(	NULL
DE-52	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Whatman	NULL
.	NULL

Acrylamide	NULL
,	NULL
N	NULL
,	NULL
N'-methylene	NULL
bisacrylamide	NULL
,	NULL
TEMED	NULL
,	NULL
ammonium	NULL
per-sulfate	NULL
,	NULL
2-mercaptoethanol	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
and	NULL
Coomassie	NULL
Brilliant	NULL
Blue	NULL
were	NULL
from	NULL
Bio-Rad	NULL
.	NULL

Ammonium	NULL
sulfate	NULL
was	NULL
obtained	NULL
from	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
.	NULL

MG115	NULL
,	NULL
a	NULL
20	NULL
S	NULL
proteasome	NULL
inhibitor	NULL
,	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Drs	NULL
.	NULL

J.	NULL
Adams	NULL
and	NULL
R.	NULL
Stein	NULL
,	NULL
MyoGenics	NULL
Inc.	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
.	NULL

All	NULL
tissue	NULL
culture	NULL
reagents	NULL
were	NULL
purchased	NULL
from	NULL
Biological	NULL
Industries	NULL
,	NULL
Kibbutz	NULL
Beit	NULL
Haemek	NULL
,	NULL
Israel	NULL
.	NULL

Centricon	NULL
10	NULL
microconcentrators	NULL
were	NULL
from	NULL
Amicon	NULL
.	NULL

Wheat	NULL
germ	NULL
and	NULL
rabbit	NULL
reticulocyte	NULL
lysate-based	NULL
TNT	NULL
transcription-translation	NULL
coupled	NULL
kits	NULL
were	NULL
from	NULL
Promega	NULL
.	NULL

HiLoad	NULL
Superdex	NULL
200	NULL
HR	NULL
(	NULL
16	NULL
X	NULL
600	NULL
mm	NULL
)	NULL
column	NULL
was	NULL
from	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
All	NULL
other	NULL
chemicals	NULL
were	NULL
of	NULL
high	NULL
analytical	NULL
grade	NULL
.	NULL

Cell	NULL
Line-C3.F6	NULL
B	NULL
lymphocyte	NULL
cell	NULL
line	NULL
was	NULL
obtained	NULL
from	NULL
Dr.	NULL
Osami	NULL
Kanagawa	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Generation	NULL
of	NULL
Radiolabeled	NULL
Proteins-	NULL
[	NULL
``	NULL
°S8	NULL
)	NULL
Methionine-labeled	NULL
p105	NULL
and	NULL
p53	NULL
were	NULL
synthesized	NULL
using	NULL
a	NULL
TNT-wheat	NULL
germ-based	NULL
or	NULL
TNT-rabbit	NULL
reticulocyte-based	NULL
transcription-translation	NULL
coupled	NULL
systems	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
NF-kB	NULL
Precursor	NULL
Processing	NULL
by	NULL
the	NULL
Ubiquitin	NULL
System	NULL
Translations	NULL
were	NULL
carried	NULL
out	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
in	NULL
reaction	NULL
mixtures	NULL
containing	NULL
100	NULL
pl	NULL
of	NULL
extracts	NULL
and	NULL
4	NULL
ug	NULL
of	NULL
circular	NULL
plasmid	NULL
containing	NULL
the	NULL
appropriate	NULL
cDNAs	NULL
.	NULL

E6	NULL
was	NULL
generated	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
,	NULL
except	NULL
that	NULL
the	NULL
labeled	NULL
amino	NULL
acid	NULL
was	NULL
replaced	NULL
with	NULL
0.1	NULL
mM	NULL
unlabeled	NULL
methionine	NULL
.	NULL

When	NULL
indicated	NULL
,	NULL
the	NULL
translation	NULL
mixture	NULL
containing	NULL
the	NULL
labeled	NULL
substrate	NULL
was	NULL
resolved	NULL
on	NULL
DEAE	NULL
to	NULL
remove	NULL
ubiquitin	NULL
and	NULL
£2-F1	NULL
,	NULL
and	NULL
other	NULL
potential	NULL
Fraction	NULL
I-contain-ing	NULL
E2	NULL
enzymes	NULL
(	NULL
26	NULL
,	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
all	NULL
E2	NULL
enzymes	NULL
,	NULL
including	NULL
E2-F1	NULL
,	NULL
contained	NULL
in	NULL
the	NULL
translation	NULL
extract	NULL
,	NULL
were	NULL
inactivated	NULL
following	NULL
translation	NULL
by	NULL
incubating	NULL
the	NULL
reaction	NULL
mixture	NULL
with	NULL
NEM	NULL
(	NULL
10	NULL
mm	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
)	NULL
.	NULL

The	NULL
inhibitor	NULL
was	NULL
neutralized	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
6	NULL
mM	NULL
DTT	NULL
.	NULL

'**I-Labeled	NULL
lysozyme	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
chloram-ine-T	NULL
method	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Rabbit	NULL
Reticulocyte	NULL
Lysate	NULL
and	NULL
Conjugating	NULL
En-zymes-Reticulocyte-rich	NULL
blood	NULL
was	NULL
induced	NULL
in	NULL
rabbits	NULL
by	NULL
successive	NULL
injections	NULL
of	NULL
phenylhydrazine	NULL
,	NULL
and	NULL
lysate	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Fractionation	NULL
of	NULL
the	NULL
lysate	NULL
into	NULL
Fraction	NULL
I	NULL
,	NULL
which	NULL
contains	NULL
ubiquitin	NULL
and	NULL
£2-F1	NULL
,	NULL
and	NULL
Fraction	NULL
II	NULL
,	NULL
which	NULL
contains	NULL
several	NULL
£2	NULL
enzymes	NULL
,	NULL
all	NULL
known	NULL
E3	NULL
enzymes	NULL
,	NULL
and	NULL
the	NULL
26	NULL
S	NULL
proteasome	NULL
complex	NULL
,	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
31	NULL
)	NULL
.	NULL

E1	NULL
,	NULL
£2-14-kDa	NULL
,	NULL
and	NULL
E38	NULL
«	NULL
were	NULL
purified	NULL
from	NULL
Fraction	NULL
II	NULL
by	NULL
affinity	NULL
chromatography	NULL
over	NULL
immobilized	NULL
ubiquitin	NULL
and	NULL
immobilized	NULL
B-lactoglobulin	NULL
as	NULL
described	NULL
(	NULL
82	NULL
)	NULL
.	NULL

E2-F1	NULL
was	NULL
purified	NULL
to	NULL
homogeneity	NULL
from	NULL
Fraction	NULL
I	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Recombinant	NULL
UbeHS5	NULL
,	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
£2-F1	NULL
(	NULL
Ref	NULL
.	NULL

30	NULL
;	NULL
the	NULL
encoding	NULL
cDNA	NULL
cloned	NULL
into	NULL
a	NULL
pET3a	NULL
vetor	NULL
was	NULL
kindly	NULL
obtained	NULL
from	NULL
Dr.	NULL
Martin	NULL
Scheffner	NULL
,	NULL
DKFZ	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
was	NULL
purified	NULL
from	NULL
bacterial	NULL
extracts	NULL
after	NULL
induction	NULL
as	NULL
follows	NULL
.	NULL

Extracts	NULL
(	NULL
from	NULL
1	NULL
liter	NULL
of	NULL
cultured	NULL
cells	NULL
)	NULL
were	NULL
chromato-graphed	NULL
on	NULL
DEAE-anion	NULL
exchange	NULL
resin	NULL
(	NULL
81	NULL
)	NULL
,	NULL
and	NULL
Fraction	NULL
I	NULL
was	NULL
resolved	NULL
by	NULL
ammonium	NULL
sulfate	NULL
precipitation	NULL
into	NULL
two	NULL
portions	NULL
,	NULL
0-38	NULL
%	NULL
and	NULL
42-80	NULL
%	NULL
.	NULL

The	NULL
42-80	NULL
%	NULL
precipitate	NULL
was	NULL
dissolved	NULL
in	NULL
a	NULL
small	NULL
volume	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
resolved	NULL
via	NULL
gel	NULL
filtration	NULL
chromatography	NULL
on	NULL
a	NULL
HiLoad	NULL
Superdex	NULL
75	NULL
HR	NULL
(	NULL
16	NULL
x	NULL
600	NULL
mm	NULL
)	NULL
column	NULL
in	NULL
a	NULL
similar	NULL
buffer	NULL
containing	NULL
also	NULL
150	NULL
mM	NULL
NaCl	NULL
.	NULL

Fractions	NULL
of	NULL
2.4	NULL
ml	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
UbeHS5	NULL
was	NULL
identified	NULL
following	NULL
staining	NULL
with	NULL
Coomassie	NULL
Brilliant	NULL
Blue	NULL
.	NULL

We	NULL
obtained	NULL
1	NULL
mg	NULL
of	NULL
~90	NULL
%	NULL
homogeneous	NULL
protein	NULL
.	NULL

Initial	NULL
Characterization	NULL
of	NULL
p105	NULL
NF-	NULL
«	NULL
B	NULL
Precursor-Ubiquitin	NULL
Ligase	NULL
,	NULL
E3-Fraction	NULL
II	NULL
was	NULL
fractionated	NULL
by	NULL
(	NULL
NH	NULL
,	NULL
)	NULL
,80	NULL
,	NULL
into	NULL
Fraction	NULL
IIA	NULL
(	NULL
O-38	NULL
%	NULL
)	NULL
and	NULL
Fraction	NULL
IIB	NULL
(	NULL
42-80	NULL
%	NULL
)	NULL
as	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

2	NULL
ml	NULL
of	NULL
Fraction	NULL
IIA	NULL
(	NULL
20	NULL
mg/ml	NULL
)	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
HiLoad	NULL
Superdex	NULL
200	NULL
HR	NULL
(	NULL
16	NULL
x	NULL
600	NULL
mm	NULL
)	NULL
gel	NULL
filtration	NULL
chromatography	NULL
column	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
resolved	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
DTT	NULL
(	NULL
buffer	NULL
A	NULL
)	NULL
using	NULL
an	NULL
FPLC	NULL
system	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

2.4-ml	NULL
fractions	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
salt	NULL
was	NULL
removed	NULL
by	NULL
repeated	NULL
concentration-dilu-tion	NULL
cycles	NULL
using	NULL
Centricon	NULL
10	NULL
microconcentrators	NULL
with	NULL
buffer	NULL
A	NULL
that	NULL
does	NULL
not	NULL
contain	NULL
NaCl	NULL
.	NULL

Fractions	NULL
were	NULL
concentrated	NULL
to	NULL
100	NULL
ul	NULL
.	NULL

Preparation	NULL
of	NULL
Cell	NULL
Extract-C3.F6	NULL
B	NULL
Cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
in	NULL
hypotonic	NULL
lysis	NULL
buffer	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
cells/2	NULL
ml	NULL
of	NULL
buffer	NULL
)	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
and	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
.	NULL

Lysis	NULL
was	NULL
completed	NULL
using	NULL
a	NULL
Dounce	NULL
homoge-nizer	NULL
and	NULL
was	NULL
followed	NULL
microscopically	NULL
.	NULL

Nuclei	NULL
were	NULL
removed	NULL
and	NULL
cytosolic	NULL
extract	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Extracts	NULL
contained	NULL
~8-10	NULL
mg	NULL
of	NULL
protein/ml	NULL
.	NULL

Fraction	NULL
I	NULL
and	NULL
Fraction	NULL
II	NULL
from	NULL
cytosol	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
similar	NULL
fractions	NULL
from	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
see	NULL
above	NULL
)	NULL
.	NULL

Processing	NULL
of	NULL
p105-	NULL
[	NULL
*°8\Methionine-labeled	NULL
p105	NULL
was	NULL
processed	NULL
to	NULL
p50	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
containing	NULL
,	NULL
in	NULL
25	NULL
wl	NULL
of	NULL
reaction	NULL
mixture	NULL
,	NULL
the	NULL
following	NULL
processing	NULL
extracts	NULL
:	NULL
crude	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
10	NULL
pl	NULL
;	NULL
~1	NULL
mg	NULL
of	NULL
protein	NULL
)	NULL
or	NULL
C3.F6	NULL
cytosolic	NULL
extract	NULL
,	NULL
crude	NULL
reticulocyte	NULL
Fraction	NULL
II	NULL
,	NULL
or	NULL
wheat	NULL
germ	NULL
extract	NULL
(	NULL
~100	NULL
ug	NULL
protein	NULL
of	NULL
each	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
reaction	NULL
mixture	NULL
contained	NULL
:	NULL
40	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
5	NULL
mM	NULL
KCl	NULL
,	NULL
5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
ubiquitin	NULL
(	NULL
4	NULL
ug	NULL
unless	NULL
otherwise	NULL
indicated	NULL
)	NULL
,	NULL
and	NULL
~40,000	NULL
cpm	NULL
of	NULL
the	NULL
labeled	NULL
substrate	NULL
.	NULL

Reactions	NULL
without	NULL
ATP	NULL
contained	NULL
20	NULL
mM	NULL
2-de-oxyglucose	NULL
and	NULL
0.2	NULL
ug	NULL
of	NULL
hexokinase	NULL
.	NULL

ATP-dependent	NULL
processing	NULL
was	NULL
preformed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.5	NULL
mM	NULL
ATP	NULL
,	NULL
10	NULL
mM	NULL
phosphocreatine	NULL
,	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
creatine	NULL
kinase	NULL
.	NULL

All	NULL
reaction	NULL
mixtures	NULL
were	NULL
preincubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
37°C	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
substrate	NULL
.	NULL

Mixtures	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
on	NULL
ice	NULL
or	NULL
at	NULL
37°C	NULL
.	NULL

Mixtures	NULL
incubated	NULL
on	NULL
ice	NULL
contained	NULL
ATP	NULL
and	NULL
ATP-regenerating	NULL
system	NULL
.	NULL

Following	NULL
incubation	NULL
,	NULL
15-ul	NULL
aliquots	NULL
from	NULL
the	NULL
reaction	NULL
mixtures	NULL
were	NULL
resolved	NULL
via	NULL
SDS-PAGE	NULL
(	NULL
10	NULL
%	NULL
acrylamide	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
fluorographed	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
XAR-5	NULL
Kodak	NULL
film	NULL
or	NULL
,	NULL
when	NULL
indicated	NULL
,	NULL
analyzed	NULL
by	NULL
PhosphorImager	NULL
(	NULL
Fuji	NULL
)	NULL
.	NULL

Conjugation	NULL
Assay-Ubiquitin-p105	NULL
conjugates	NULL
were	NULL
generated	NULL
in	NULL
an	NULL
assay	NULL
similar	NULL
to	NULL
that	NULL
used	NULL
for	NULL
processing	NULL
,	NULL
but	NULL
with	NULL
the	NULL
following	NULL
modi-fications	NULL
.	NULL

1	NULL
)	NULL
Reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
10	NULL
pl	NULL
,	NULL
and	NULL
the	NULL
concentrations	NULL
of	NULL
all	NULL
components	NULL
were	NULL
adjusted	NULL
accordingly	NULL
;	NULL
2	NULL
)	NULL
ATPyS	NULL
(	NULL
5	NULL
mm	NULL
)	NULL
substituted	NULL
for	NULL
ATP	NULL
and	NULL
ATP-regenerating	NULL
system	NULL
;	NULL
3	NULL
)	NULL
ubiquitin	NULL
21709	NULL
ATP	NULL
mou	NULL
$	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
0	NULL
10	NULL
1	NULL
Ori	NULL
.	NULL

_	NULL
kDa	NULL
97.4	NULL
—	NULL
!	NULL

69.0	NULL
46.0	NULL
-	NULL
WE	NULL
,	NULL
«	NULL
<	NULL
-	NULL
p5So	NULL
30.0	NULL
--	NULL
21.5	NULL
14.3	NULL
.-D.F	NULL
.	NULL

0	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

ATP-dependent	NULL
processing	NULL
of	NULL
p105	NULL
.	NULL

Labeled	NULL
p105	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
C3.F6	NULL
cytosolic	NULL
extract	NULL
.	NULL

Incubation	NULL
was	NULL
carried	NULL
out	NULL
on	NULL
ice	NULL
or	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
ATP	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
and	NULL
in	NULL
the	NULL
figure	NULL
,	NULL
and	NULL
appearance	NULL
of	NULL
p50	NULL
was	NULL
monitored	NULL
.	NULL

Ori	NULL
.	NULL

and	NULL
D.F	NULL
.	NULL

denote	NULL
origin	NULL
of	NULL
gel	NULL
and	NULL
dye	NULL
front	NULL
,	NULL
respectively	NULL
.	NULL

Molecular	NULL
size	NULL
markers	NULL
are	NULL
:	NULL
phosphorylase	NULL
b	NULL
,	NULL
97.4	NULL
kDa	NULL
;	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
69.0	NULL
kDa	NULL
;	NULL
ovalbumin	NULL
,	NULL
46.0	NULL
kDa	NULL
;	NULL
car-bonic	NULL
anhydrase	NULL
,	NULL
30.0	NULL
kDa	NULL
;	NULL
soybean	NULL
trypsin	NULL
inhibitor	NULL
,	NULL
21.0	NULL
kDa	NULL
;	NULL
lysozyme	NULL
,	NULL
14.3	NULL
kDa	NULL
.	NULL

aldehyde	NULL
(	NULL
0.5	NULL
ug	NULL
;	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
certain	NULL
isopeptidases	NULL
)	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
ovalbumin	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
.	NULL

Reactions	NULL
were	NULL
incubated	NULL
at	NULL
37	NULL
°C	NULL
for	NULL
1	NULL
h	NULL
,	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
(	NULL
7	NULL
%	NULL
)	NULL
,	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Preparation	NULL
of	NULL
MeUb-Reductively	NULL
methylated	NULL
ubiquitin	NULL
(	NULL
MeUb	NULL
)	NULL
was	NULL
prepared	NULL
from	NULL
ubiquitin	NULL
as	NULL
described	NULL
(	NULL
36	NULL
)	NULL
.	NULL

RESULTS	NULL
p50	NULL
Is	NULL
Synthesized	NULL
from	NULL
p105	NULL
in	NULL
an	NULL
ATP-dependent	NULL
Proc-ess-As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
in	NULL
vitro	NULL
processing	NULL
of	NULL
p105	NULL
requires	NULL
ATP	NULL
.	NULL

Similar	NULL
results	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
were	NULL
published	NULL
by	NULL
Fan	NULL
and	NULL
Maniatis	NULL
(	NULL
9	NULL
)	NULL
using	NULL
p60	NULL
,	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
p105	NULL
.	NULL

We	NULL
also	NULL
demonstrated	NULL
that	NULL
p50	NULL
is	NULL
generated	NULL
from	NULL
p105	NULL
in	NULL
a	NULL
time-dependent	NULL
manner	NULL
.	NULL

Following	NULL
a	NULL
short	NULL
translation	NULL
(	NULL
pulse	NULL
)	NULL
,	NULL
the	NULL
predominant	NULL
form	NULL
generated	NULL
is	NULL
p105	NULL
.	NULL

When	NULL
translation	NULL
is	NULL
inhibited	NULL
(	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
excess	NULL
unlabeled	NULL
methi-onine	NULL
and	NULL
RNase	NULL
A	NULL
)	NULL
and	NULL
p105	NULL
is	NULL
further	NULL
incubated	NULL
(	NULL
chase	NULL
)	NULL
,	NULL
an	NULL
increasing	NULL
amount	NULL
of	NULL
p50	NULL
is	NULL
generated	NULL
with	NULL
time	NULL
at	NULL
the	NULL
expense	NULL
of	NULL
the	NULL
precursor	NULL
molecule	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

p105	NULL
Is	NULL
Processed	NULL
and	NULL
Conjugated	NULL
in	NULL
Mammalian	NULL
but	NULL
Not	NULL
in	NULL
Wheat	NULL
Germ	NULL
Extract-Since	NULL
only	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
p105	NULL
protein	NULL
is	NULL
synthesized	NULL
in	NULL
the	NULL
in	NULL
vitro	NULL
cell-free	NULL
translation	NULL
system	NULL
,	NULL
it	NULL
is	NULL
virtually	NULL
impossible	NULL
to	NULL
isolate	NULL
it	NULL
from	NULL
the	NULL
many	NULL
components	NULL
of	NULL
the	NULL
ubiquitin	NULL
proteolytic	NULL
system	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
was	NULL
important	NULL
to	NULL
attempt	NULL
to	NULL
generate	NULL
a	NULL
substrate	NULL
that	NULL
will	NULL
not	NULL
be	NULL
conjugated	NULL
or	NULL
processed	NULL
co-translationally	NULL
.	NULL

Scheffner	NULL
and	NULL
colleagues	NULL
(	NULL
87	NULL
)	NULL
reported	NULL
that	NULL
p53	NULL
is	NULL
conjugated	NULL
by	NULL
a	NULL
specific	NULL
E3	NULL
enzyme	NULL
,	NULL
designated	NULL
E6-AP	NULL
,	NULL
that	NULL
is	NULL
present	NULL
in	NULL
mammalian	NULL
cell	NULL
but	NULL
not	NULL
in	NULL
wheat	NULL
germ	NULL
extract	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
p105-ubiquitin	NULL
ligase	NULL
and/or	NULL
a	NULL
different	NULL
component	NULL
of	NULL
the	NULL
conjugating	NULL
machinery	NULL
demonstrates	NULL
a	NULL
similar	NULL
plant-animal	NULL
kingdom	NULL
distribution	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
reticulocyte	NULL
lysate	NULL
and	NULL
C3.F6	NULL
B	NULL
cell	NULL
cytosol	NULL
can	NULL
process	NULL
p105	NULL
to	NULL
p50	NULL
.	NULL

In	NULL
striking	NULL
con-trast	NULL
,	NULL
wheat	NULL
germ	NULL
extract	NULL
is	NULL
inactive	NULL
.	NULL

In	NULL
correlation	NULL
with	NULL
this	NULL
finding	NULL
,	NULL
conjugation	NULL
of	NULL
ubiquitin	NULL
to	NULL
p105	NULL
also	NULL
occurs	NULL
in	NULL
the	NULL
mammalian	NULL
cell	NULL
extracts	NULL
but	NULL
not	NULL
in	NULL
the	NULL
plant	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

We	NULL
noted	NULL
that	NULL
both	NULL
processing	NULL
and	NULL
conjugation	NULL
are	NULL
more	NULL
efficient	NULL
in	NULL
the	NULL
lymphocyte	NULL
cytosol	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
an	NULL
essential	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
21710	NULL
enzyme	NULL
is	NULL
rate-limiting	NULL
in	NULL
the	NULL
reticulocyte	NULL
extract	NULL
or	NULL
that	NULL
an	NULL
unidentified	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
process	NULL
is	NULL
present	NULL
in	NULL
the	NULL
lymphocyte	NULL
but	NULL
not	NULL
in	NULL
the	NULL
rabbit	NULL
reticulocyte	NULL
extract	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
increasing	NULL
concentrations	NULL
of	NULL
reticulocyte	NULL
extract	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
efficiency	NULL
of	NULL
processing	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Multiple	NULL
Ubiquitination	NULL
of	NULL
p105	NULL
Is	NULL
Essential	NULL
for	NULL
Process-ing-In	NULL
order	NULL
to	NULL
demonstrate	NULL
that	NULL
ubiquitination	NULL
is	NULL
an	NULL
essential	NULL
intermediate	NULL
step	NULL
in	NULL
processing	NULL
of	NULL
p105	NULL
,	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
show	NULL
that	NULL
inhibition	NULL
of	NULL
one	NULL
process	NULL
leads	NULL
to	NULL
suppression	NULL
of	NULL
the	NULL
other	NULL
as	NULL
well	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
conjugation	NULL
in	NULL
crude	NULL
extract	NULL
is	NULL
extremely	NULL
inefficient	NULL
and	NULL
can	NULL
be	NULL
stimulated	NULL
significantly	NULL
only	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
free	NULL
ubiquitin	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

This	NULL
may	NULL
not	NULL
be	NULL
surprising	NULL
,	NULL
as	NULL
most	NULL
of	NULL
the	NULL
ubiquitin	NULL
in	NULL
the	NULL
extract	NULL
may	NULL
be	NULL
``	NULL
trapped	NULL
``	NULL
in	NULL
conjugates	NULL
,	NULL
and	NULL
the	NULL
level	NULL
of	NULL
free	NULL
ubiquitin	NULL
is	NULL
rather	NULL
low	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
MeUb	NULL
to	NULL
a	NULL
system	NULL
that	NULL
contains	NULL
also	NULL
exogenously	NULL
added	NULL
free	NULL
ubiquitin	NULL
inhibited	NULL
conjugation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
and	NULL
,	NULL
consequently	NULL
,	NULL
processing	NULL
of	NULL
p105	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

MeUb	NULL
is	NULL
an	NULL
analogue	NULL
of	NULL
ubiquitin	NULL
in	NULL
which	NULL
all	NULL
the	NULL
free	NULL
-NH	NULL
,	NULL
groups	NULL
have	NULL
been	NULL
modified	NULL
.	NULL

It	NULL
acts	NULL
as	NULL
a	NULL
chain	NULL
terminator	NULL
and	NULL
inhibits	NULL
the	NULL
formation	NULL
of	NULL
polyubiquitin	NULL
chains	NULL
that	NULL
are	NULL
essential	NULL
for	NULL
recognition	NULL
of	NULL
the	NULL
adduct	NULL
by	NULL
the	NULL
26	NULL
S	NULL
proteasome	NULL
complex	NULL
.	NULL

Consequently	NULL
,	NULL
introduction	NULL
of	NULL
this	NULL
derivative	NULL
leads	NULL
to	NULL
inhibition	NULL
of	NULL
degradation	NULL
(	NULL
36	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
excess	NULL
free	NULL
ubiquitin	NULL
alleviated	NULL
inhibition	NULL
of	NULL
both	NULL
conjugation	NULL
and	NULL
processing	NULL
(	NULL
Figs	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
conjugation	NULL
of	NULL
ubiquitin	NULL
is	NULL
an	NULL
essential	NULL
intermediate	NULL
step	NULL
in	NULL
processing	NULL
of	NULL
p105	NULL
.	NULL

In	NULL
the	NULL
processing	NULL
reaction	NULL
we	NULL
noted	NULL
the	NULL
appearance	NULL
of	NULL
an	NULL
additional	NULL
processed	NULL
form	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
kDa	NULL
«	NULL
a-	NULL
p1O5	NULL
97.4	NULL
pss	NULL
wun	NULL
gue	NULL
69.0	NULL
e	NULL
T	NULL
souk	NULL
Cl	NULL
|	NULL
_	NULL
|	NULL
050	NULL
46.0	NULL
we	NULL
--	NULL
4	NULL
30.0	NULL
___	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Lymphocyte	NULL
and	NULL
reticulocyte	NULL
extracts	NULL
,	NULL
but	NULL
not	NULL
wheat	NULL
germ	NULL
extract	NULL
,	NULL
can	NULL
process	NULL
p105	NULL
.	NULL

Wheat	NULL
germ-translated	NULL
p105	NULL
was	NULL
incubated	NULL
in	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
,	NULL
in	NULL
C3.F6	NULL
cytosolic	NULL
extract	NULL
{	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
in	NULL
wheat	NULL
germ	NULL
extract	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
procedures	NULL
.	NULL
``	NULL

Lane	NULL
1	NULL
,	NULL
incubation	NULL
on	NULL
ice	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
incubation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
ATP	NULL
;	NULL
lanes	NULL
3-5	NULL
,	NULL
incubation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ATP	NULL
.	NULL

Notes	NULL
and	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

1	NULL
2	NULL
3	NULL
NF-kB	NULL
Precursor	NULL
Processing	NULL
by	NULL
the	NULL
Ubiquitin	NULL
System	NULL
of	NULL
a	NULL
slightly	NULL
higher	NULL
molecular	NULL
mass	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

This	NULL
form	NULL
may	NULL
be	NULL
a	NULL
processing	NULL
intermediate	NULL
or	NULL
a	NULL
product	NULL
that	NULL
was	NULL
processed	NULL
in	NULL
a	NULL
different	NULL
site	NULL
.	NULL

We	NULL
noted	NULL
the	NULL
appearance	NULL
of	NULL
this	NULL
product	NULL
,	NULL
although	NULL
in	NULL
lower	NULL
amounts	NULL
,	NULL
in	NULL
most	NULL
of	NULL
the	NULL
processing	NULL
reactions	NULL
(	NULL
see	NULL
,	NULL
for	NULL
example	NULL
,	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
;	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
in	NULL
the	NULL
pulse-chase	NULL
experiment	NULL
demonstrating	NULL
precursor-product	NULL
relationships	NULL
between	NULL
p105	NULL
and	NULL
p50	NULL
(	NULL
see	NULL
above	NULL
)	NULL
,	NULL
this	NULL
upper	NULL
form	NULL
diminished	NULL
with	NULL
time	NULL
,	NULL
supporting	NULL
the	NULL
notion	NULL
that	NULL
it	NULL
may	NULL
well	NULL
be	NULL
a	NULL
processing	NULL
intermediate	NULL
;	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Ubiquitin-Carrier	NULL
Protein	NULL
E2-F1	NULL
Is	NULL
Essential	NULL
for	NULL
Conjugation	NULL
of	NULL
p105-In	NULL
order	NULL
to	NULL
identify	NULL
the	NULL
enzymatic	NULL
components	NULL
involved	NULL
in	NULL
conjugation	NULL
of	NULL
p105	NULL
,	NULL
we	NULL
gradually	NULL
reconstituted	NULL
the	NULL
conjugation	NULL
system	NULL
from	NULL
several	NULL
essential	NULL
components	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
(	NULL
pane	NULL
!	NULL

A-1	NULL
)	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
ubiquitin	NULL
to	NULL
crude	NULL
reticulocyte	NULL
Fraction	NULL
II	NULL
was	NULL
sufficient	NULL
to	NULL
promote	NULL
efficient	NULL
conjugation	NULL
(	NULL
compare	NULL
lane	NULL
I	NULL
to	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

According	NULL
to	NULL
this	NULL
result	NULL
,	NULL
one	NULL
may	NULL
conclude	NULL
that	NULL
the	NULL
£2	NULL
is	NULL
contained	NULL
in	NULL
Fraction	NULL
II	NULL
.	NULL

It	NULL
can	NULL
be	NULL
any	NULL
of	NULL
the	NULL
many	NULL
E2	NULL
enzymes	NULL
contained	NULL
in	NULL
this	NULL
fraction	NULL
,	NULL
including	NULL
E2-14	NULL
kDa	NULL
and	NULL
E2-25	NULL
kDa	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Not	NULL
surprisingly	NULL
,	NULL
addition	NULL
of	NULL
£2-14	NULL
kDa	NULL
(	NULL
that	NULL
as	NULL
noted	NULL
is	NULL
present	NULL
in	NULL
Fraction	NULL
II	NULL
)	NULL
did	NULL
not	NULL
affect	NULL
conjugation	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
noted	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
conjugation	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
E2-F1	NULL
enzyme	NULL
that	NULL
is	NULL
derived	NULL
from	NULL
Fraction	NULL
I	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
Palombella	NULL
and	NULL
colleagues	NULL
(	NULL
12	NULL
)	NULL
also	NULL
reported	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
ubiquitin	NULL
to	NULL
Fraction	NULL
II	NULL
is	NULL
sufficient	NULL
to	NULL
promote	NULL
processing	NULL
.	NULL

Thus	NULL
,	NULL
their	NULL
results	NULL
obtained	NULL
in	NULL
crude	NULL
Fraction	NULL
II	NULL
,	NULL
using	NULL
p60	NULL
as	NULL
a	NULL
substrate	NULL
,	NULL
are	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
experiment	NULL
reported	NULL
here	NULL
.	NULL

However	NULL
,	NULL
the	NULL
slight	NULL
increase	NULL
in	NULL
conjugation	NULL
observed	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
E2-F1	NULL
(	NULL
panel	NULL
!	NULL

A-I	NULL
,	NULL
compare	NULL
lane	NULL
4	NULL
to	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
raised	NULL
the	NULL
suspicion	NULL
that	NULL
this	NULL
enzyme	NULL
(	NULL
alone	NULL
or	NULL
with	NULL
its	NULL
Fraction	NULL
I	NULL
homologs	NULL
)	NULL
is	NULL
involved	NULL
in	NULL
conjugation	NULL
and	NULL
is	NULL
contained	NULL
in	NULL
the	NULL
translation	NULL
extract	NULL
added	NULL
with	NULL
the	NULL
labeled	NULL
substrate	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
carried	NULL
un-noticed	NULL
into	NULL
the	NULL
reaction	NULL
mixture	NULL
and	NULL
catalyzes	NULL
conjugation	NULL
of	NULL
p105	NULL
.	NULL

Palombella	NULL
and	NULL
colleagues	NULL
(	NULL
12	NULL
)	NULL
used	NULL
a	NULL
similar	NULL
translation	NULL
extract	NULL
to	NULL
generate	NULL
their	NULL
substrate	NULL
.	NULL

To	NULL
corroborate	NULL
the	NULL
possible	NULL
involvement	NULL
of	NULL
£2-F1	NULL
in	NULL
the	NULL
conjugation	NULL
of	NULL
p105	NULL
,	NULL
we	NULL
treated	NULL
the	NULL
translation	NULL
extract	NULL
(	NULL
following	NULL
completion	NULL
of	NULL
the	NULL
reaction	NULL
)	NULL
with	NULL
NEM	NULL
,	NULL
followed	NULL
by	NULL
neutralization	NULL
of	NULL
the	NULL
reagent	NULL
with	NULL
DTT	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
panel	NULL
A-II	NULL
;	NULL
see	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
)	NULL
.	NULL

As	NULL
all	NULL
known	NULL
£2	NULL
enzymes	NULL
contain	NULL
an	NULL
essential	NULL
-SH	NULL
group	NULL
necessary	NULL
for	NULL
their	NULL
activity	NULL
(	NULL
23	NULL
)	NULL
,	NULL
the	NULL
treatment	NULL
inactivates	NULL
the	NULL
K2	NULL
enzymes	NULL
contained	NULL
in	NULL
the	NULL
extract	NULL
.	NULL

Indeed	NULL
,	NULL
when	NULL
the	NULL
substrate-containing	NULL
extract	NULL
is	NULL
first	NULL
treated	NULL
with	NULL
NEM	NULL
,	NULL
conjugation	NULL
becomes	NULL
completely	NULL
dependent	NULL
upon	NULL
the	NULL
addition	NULL
of	NULL
£E2-F1	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
(	NULL
panel	NULL
A-I1	NULL
)	NULL
,	NULL
addition	NULL
of	NULL
ubiquitin	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
and	NULL
£E2-14	NULL
kDa	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
promote	NULL
conjugation	NULL
.	NULL

Only	NULL
addition	NULL
of	NULL
purified	NULL
E2-F1	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
restored	NULL
conjugation	NULL
.	NULL

Using	NULL
a	NULL
different	NULL
approach	NULL
,	NULL
we	NULL
resolved	NULL
the	NULL
translation	NULL
mixture	NULL
on	NULL
DEAE-cellulose	NULL
to	NULL
Fraction	NULL
I	NULL
and	NULL
Fraction	NULL
II	NULL
.	NULL

The	NULL
substrate	NULL
is	NULL
contained	NULL
in	NULL
Fraction	NULL
II	NULL
,	NULL
whereas	NULL
E2-F1	NULL
is	NULL
resolved	NULL
with	NULL
Fraction	NULL
I	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
the	NULL
resolved	NULL
substrate	NULL
to	NULL
Frac-	NULL
4	NULL
5	NULL
6	NULL
7	NULL
wis	NULL
Conj	NULL
.	NULL

-	NULL
Ori	NULL
.	NULL

kDa	NULL
p105	NULL
-	NULL
-	NULL
»	NULL
--	NULL
97.4	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Lymphocyte	NULL
and	NULL
reticulocyte	NULL
extracts	NULL
,	NULL
but	NULL
not	NULL
wheat	NULL
germ	NULL
extract	NULL
,	NULL
can	NULL
conjugate	NULL
ubiquitin	NULL
to	NULL
p105	NULL
.	NULL

Labeled	NULL
p105	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
anes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
C3.F6	NULL
cytosolic	NULL
extract	NULL
(	NULL
Zanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
and	NULL
wheat	NULL
germ	NULL
extract	NULL
(	NULL
Zanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
Zanes	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
7	NULL
)	NULL
of	NULL
ATPyS	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
substrate	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cell	NULL
extract	NULL
,	NULL
but	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ATPyS	NULL
.	NULL

Conjugates	NULL
were	NULL
synthesized	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Con	NULL
;	NULL
.	NULL

denotes	NULL
ubiquitin	NULL
conjugates	NULL
.	NULL

Notes	NULL
and	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
NF-kB	NULL
Precursor	NULL
Processing	NULL
by	NULL
the	NULL
Ubiquitin	NULL
System	NULL
ATP-	NULL
y	NULL
-s	NULL
=o	NULL
=	NULL
+	NULL
+00	NULL
+	NULL
+	NULL
+	NULL
Ubiquitin	NULL
(	NULL
ug	NULL
)	NULL
-	NULL
-_	NULL
8	NULL
0	NULL
1	NULL
2	NULL
4	NULL
was	NULL
-	NULL
.	NULL

‘	NULL
__	NULL
Ori	NULL
.	NULL

Con|	NULL
.	NULL

kDa	NULL
105	NULL
«	NULL
fie	NULL
~	NULL
~	NULL
--	NULL
-	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Ubiquitin-dependent	NULL
conjugation	NULL
of	NULL
p105	NULL
.	NULL

Conjugation	NULL
of	NULL
ubiquitin	NULL
to	NULL
p105	NULL
was	NULL
monitored	NULL
in	NULL
reaction	NULL
mixtures	NULL
containing	NULL
C3.F6	NULL
cytosolic	NULL
extract	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Ubiquitin	NULL
and	NULL
ATPyS	NULL
were	NULL
added	NULL
as	NULL
indicated	NULL
.	NULL

Con	NULL
}	NULL
.	NULL

denotes	NULL
ubiquitin	NULL
conjugates	NULL
.	NULL

Notes	NULL
and	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Ubiquitin	NULL
{	NULL
(	NULL
ug	NULL
)	NULL
4	NULL
2	NULL
4	NULL
4	NULL
4	NULL
4	NULL
12	NULL
MeUb	NULL
{	NULL
(	NULL
ug	NULL
)	NULL
200	NULL
.	NULL

-	NULL
8	NULL
16	NULL
24	NULL
24	NULL
ATP-y—S	NULL
-o	NULL
ot	NULL
book	NULL
+	NULL
4	NULL
o+	NULL
#	NULL
Con|	NULL
.	NULL

E	NULL
ye	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

MeUb	NULL
inhibits	NULL
conjugation	NULL
of	NULL
p105	NULL
,	NULL
and	NULL
suppression	NULL
is	NULL
alleviated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
excess	NULL
free	NULL
ubiquitin	NULL
.	NULL

Conjugation	NULL
of	NULL
ubiquitin	NULL
to	NULL
p105	NULL
was	NULL
monitored	NULL
in	NULL
reaction	NULL
mixtures	NULL
containing	NULL
C3.F6	NULL
cytosolic	NULL
extract	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Reaction	NULL
mixtures	NULL
contained	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
ubiquitin	NULL
and	NULL
MeUb	NULL
.	NULL

ATPyS	NULL
was	NULL
added	NULL
or	NULL
omitted	NULL
as	NULL
indicated	NULL
.	NULL

Cong	NULL
.	NULL

denotes	NULL
ubiquitin	NULL
conjugates	NULL
.	NULL

Notes	NULL
and	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Ubiquitin	NULL
(	NULL
ug	NULL
)	NULL
-	NULL
Good	NULL
O11	NULL
4	NULL
8	NULL
16	NULL
MeUb	NULL
(	NULL
ug	NULL
)	NULL
Loe	NULL
-	NULL
3	NULL
6	NULL
9	NULL
g	NULL
9g	NULL
g	NULL
kDa	NULL
105	NULL
p	NULL
**	NULL
--	NULL
97.4	NULL
-	NULL
69.0	NULL
50	NULL
P	NULL
nid	NULL
|-	NULL
46.0	NULL
ATP	NULL
sos	NULL
%	NULL
4	NULL
$	NULL
#	NULL
t	NULL
#	NULL
+	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
e	NULL
a	NULL
a	NULL
a	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

MeUb	NULL
inhibits	NULL
processing	NULL
of	NULL
p105	NULL
,	NULL
and	NULL
inhibition	NULL
is	NULL
alleviated	NULL
by	NULL
excess	NULL
free	NULL
ubiquitin	NULL
.	NULL

Processing	NULL
of	NULL
p105	NULL
was	NULL
monitored	NULL
in	NULL
reaction	NULL
mixtures	NULL
containing	NULL
C3.F6	NULL
cytosolic	NULL
extract	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Reaction	NULL
mixtures	NULL
contained	NULL
the	NULL
displayed	NULL
amounts	NULL
of	NULL
ubiquitin	NULL
and	NULL
MeUb	NULL
.	NULL

ATP	NULL
was	NULL
added	NULL
or	NULL
omitted	NULL
from	NULL
reaction	NULL
mixtures	NULL
as	NULL
marked	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
or	NULL
at	NULL
37°C	NULL
as	NULL
indicated	NULL
.	NULL

Notes	NULL
and	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1.	NULL
tion	NULL
II	NULL
derived	NULL
from	NULL
either	NULL
lymphocytes	NULL
or	NULL
rabbit	NULL
reticulocytes	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
conjugation	NULL
unless	NULL
both	NULL
ubiquitin	NULL
and	NULL
K2-F1	NULL
were	NULL
added	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
the	NULL
remote	NULL
possibility	NULL
that	NULL
the	NULL
homogeneously	NULL
purified	NULL
E2-F1	NULL
is	NULL
contaminated	NULL
with	NULL
another	NULL
unidentified	NULL
E2	NULL
enzyme	NULL
,	NULL
we	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
purified	NULL
recombinant	NULL
UbcHS5	NULL
,	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
K2-F1	NULL
(	NULL
30	NULL
,	NULL
37	NULL
)	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
(	NULL
panel	NULL
B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
the	NULL
recombinant	NULL
enzyme	NULL
promotes	NULL
conjugation	NULL
of	NULL
p105	NULL
and	NULL
is	NULL
as	NULL
active	NULL
as	NULL
K2-F1	NULL
.	NULL

21711	NULL
A	NULL
I	NULL
I1	NULL
I	NULL
10	NULL
20	NULL
a	NULL
4I	NULL
I1	NULL
2	NULL
3	NULL
4|	NULL
v=	NULL
er	NULL
aam	NULL
(	NULL
-	NULL
Ori	NULL
.	NULL

Con	NULL
]	NULL
.	NULL

E	NULL
I	NULL
kDa	NULL
|	NULL
-	NULL
»	NULL
_	NULL
97.4	NULL
B	NULL
10	NULL
20	NULL
3	NULL
4	NULL
§	NULL
-	NULL
Ori	NULL
Con	NULL
]	NULL
.	NULL

kDa	NULL
p105	NULL
f	NULL
--	NULL
-	NULL
97.4	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

E2-F1	NULL
and	NULL
UbcHS5	NULL
,	NULL
but	NULL
not	NULL
£E2-14	NULL
kDa	NULL
are	NULL
required	NULL
for	NULL
conjugation	NULL
of	NULL
p105	NULL
.	NULL

Conjugation	NULL
of	NULL
ubiquitin	NULL
to	NULL
p105	NULL
was	NULL
followed	NULL
essentially	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
in	NULL
Fraction	NULL
II	NULL
derived	NULL
from	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
.	NULL

Panel	NULL
A	NULL
,	NULL
involvement	NULL
of	NULL
E2-F1	NULL
in	NULL
p105	NULL
conjugation	NULL
.	NULL

A-Z	NULL
,	NULL
the	NULL
labeled	NULL
substrate	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
after	NULL
synthesis	NULL
and	NULL
without	NULL
any	NULL
further	NULL
treatment	NULL
.	NULL

A-Z	NULL
,	NULL
the	NULL
labeled	NULL
substrate	NULL
was	NULL
first	NULL
treated	NULL
with	NULL
NEM	NULL
,	NULL
followed	NULL
by	NULL
neutralization	NULL
with	NULL
DTT	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Lanes	NULL
I-1	NULL
and	NULL
II-1	NULL
,	NULL
reaction	NULL
mixtures	NULL
incubated	NULL
without	NULL
ubiquitin	NULL
.	NULL

Lanes	NULL
I-2	NULL
and	NULL
II-2	NULL
,	NULL
reaction	NULL
mixtures	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
ug	NULL
of	NULL
ubiquitin	NULL
.	NULL

Lanes	NULL
1-3	NULL
and	NULL
IL-3	NULL
,	NULL
same	NULL
as	NULL
lanes	NULL
I-2	NULL
and	NULL
IL-2	NULL
,	NULL
but	NULL
with	NULL
0.2	NULL
ug	NULL
of	NULL
E2-14	NULL
kDa	NULL
.	NULL

Lanes	NULL
I-4	NULL
and	NULL
II-4	NULL
,	NULL
same	NULL
as	NULL
lanes	NULL
I-2	NULL
and	NULL
IL-2	NULL
,	NULL
but	NULL
with	NULL
0.2	NULL
ug	NULL
of	NULL
E2-F1	NULL
.	NULL

Panel	NULL
B	NULL
,	NULL
involvement	NULL
of	NULL
UbeH§	NULL
in	NULL
p105	NULL
conjugation	NULL
.	NULL

Substrate	NULL
was	NULL
treated	NULL
with	NULL
NEM	NULL
and	NULL
neutralized	NULL
with	NULL
DTT	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
(	NULL
similar	NULL
to	NULL
the	NULL
experiment	NULL
presented	NULL
in	NULL
A-I1	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
reaction	NULL
contained	NULL
all	NULL
the	NULL
components	NULL
except	NULL
for	NULL
Fraction	NULL
II	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
reaction	NULL
contained	NULL
all	NULL
the	NULL
components	NULL
except	NULL
for	NULL
ubiquitin	NULL
.	NULL

Lane	NULL
3	NULL
,	NULL
as	NULL
lane	NULL
2	NULL
,	NULL
but	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ubiquitin	NULL
.	NULL

Lane	NULL
4	NULL
,	NULL
as	NULL
lane	NULL
3	NULL
,	NULL
but	NULL
with	NULL
0.4	NULL
ug	NULL
of	NULL
recombinant	NULL
UbeHS5	NULL
.	NULL

Lane	NULL
5	NULL
,	NULL
as	NULL
lane	NULL
3	NULL
,	NULL
but	NULL
with	NULL
0.2	NULL
ug	NULL
of	NULL
purified	NULL
£2-F1	NULL
.	NULL

Cong	NULL
.	NULL

denotes	NULL
ubiquitin	NULL
conjugates	NULL
.	NULL

Notes	NULL
and	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
partial	NULL
peptide	NULL
sequences	NULL
obtained	NULL
from	NULL
E2-F1	NULL
that	NULL
is	NULL
derived	NULL
from	NULL
rabbit	NULL
(	NULL
26	NULL
)	NULL
are	NULL
not	NULL
identical	NULL
to	NULL
homologous	NULL
areas	NULL
contained	NULL
in	NULL
UbeHS	NULL
(	NULL
30	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
human	NULL
enzyme	NULL
.	NULL

Both	NULL
enzymes	NULL
,	NULL
however	NULL
,	NULL
are	NULL
contained	NULL
in	NULL
Fraction	NULL
I	NULL
and	NULL
are	NULL
involved	NULL
in	NULL
p53	NULL
conjugation	NULL
and	NULL
degradation	NULL
(	NULL
27	NULL
,	NULL
30	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
either	NULL
the	NULL
E2-F1	NULL
enzyme	NULL
is	NULL
indeed	NULL
the	NULL
rabbit	NULL
homolog	NULL
of	NULL
UbeHS5	NULL
or	NULL
,	NULL
alternatively	NULL
,	NULL
two	NULL
catalytically	NULL
similar	NULL
enzymes	NULL
exist	NULL
in	NULL
Fraction	NULL
I	NULL
.	NULL

A	NULL
Novel	NULL
Ubiquitin-Protein	NULL
Ligase	NULL
,	NULL
£3	NULL
,	NULL
Is	NULL
Involved	NULL
in	NULL
Conjugation	NULL
of	NULL
p105-Identification	NULL
of	NULL
the	NULL
£2	NULL
involved	NULL
in	NULL
conjugation	NULL
of	NULL
p105	NULL
allowed	NULL
initial	NULL
characterization	NULL
of	NULL
the	NULL
ligase	NULL
,	NULL
K3	NULL
.	NULL

We	NULL
had	NULL
previously	NULL
found	NULL
that	NULL
all	NULL
the	NULL
conjugation	NULL
activity	NULL
is	NULL
contained	NULL
in	NULL
Fraction	NULL
IIA	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
which	NULL
is	NULL
devoid	NULL
of	NULL
E1	NULL
and	NULL
known	NULL
E2	NULL
enzymes	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
appropriate	NULL
to	NULL
use	NULL
this	NULL
fraction	NULL
as	NULL
an	NULL
initial	NULL
source	NULL
for	NULL
purification	NULL
of	NULL
the	NULL
ligase	NULL
.	NULL

Indeed	NULL
,	NULL
as	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
,	NULL
Fraction	NULL
IIA	NULL
contains	NULL
an	NULL
activity	NULL
,	NULL
that	NULL
along	NULL
with	NULL
E1	NULL
and	NULL
E2-F1	NULL
(	NULL
or	NULL
recombinant	NULL
UbeHS5	NULL
,	NULL
not	NULL
shown	NULL
)	NULL
is	NULL
necessary	NULL
for	NULL
conjugation	NULL
of	NULL
p105	NULL
(	NULL
compare	NULL
lane	NULL
B	NULL
to	NULL
lane	NULL
A	NULL
)	NULL
.	NULL

Resolution	NULL
of	NULL
the	NULL
activity	NULL
by	NULL
gel	NULL
filtration	NULL
chromatography	NULL
reveals	NULL
that	NULL
the	NULL
activity	NULL
has	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
~320	NULL
kDa	NULL
.	NULL

An	NULL
identical	NULL
result	NULL
was	NULL
obtained	NULL
when	NULL
the	NULL
column	NULL
fractions	NULL
were	NULL
screened	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
recombinant	NULL
UbcH5	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
activity	NULL
is	NULL
clearly	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
E6-AP	NULL
,	NULL
the	NULL
ligase	NULL
involved	NULL
in	NULL
conjugation	NULL
of	NULL
p53	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

This	NULL
enzyme	NULL
(	NULL
40	NULL
)	NULL
,	NULL
which	NULL
has	NULL
a	NULL
molecular	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
21712	NULL
A	NULL
NF-kB	NULL
Precursor	NULL
Processing	NULL
by	NULL
the	NULL
Ubiquitin	NULL
System	NULL
~320	NULL
kDa	NULL
Y	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Ubiquitin-p1l05	NULL
ligase	NULL
is	NULL
a	NULL
novel	NULL
species	NULL
of	NULL
£3	NULL
distinct	NULL
from	NULL
EG-AP	NULL
.	NULL

Ubiquitin	NULL
conjugates	NULL
of	NULL
p105	NULL
(	NULL
panel	NULL
Con|	NULL
.	NULL

A	NULL
)	NULL
and	NULL
p53	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
were	NULL
generated	NULL
essentially	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
p53	NULL
image	NULL
was	NULL
derived	NULL
from	NULL
PhosphorImager	NULL
analysis	NULL
.	NULL

Reactions	NULL
mixtures	NULL
contained	NULL
:	NULL
0.5	NULL
ug	NULL
of	NULL
E1	NULL
,	NULL
0.15	NULL
ug	NULL
of	NULL
E2-F1	NULL
,	NULL
and	NULL
a	NULL
1.0-ul	NULL
aliquot	NULL
from	NULL
the	NULL
different	NULL
fractions	NULL
derived	NULL
from	NULL
p1Q5	NULL
~	NULL
gel	NULL
filtration	NULL
chromatography	NULL
of	NULL
Fraction	NULL
IIA	NULL
.	NULL

E6	NULL
(	NULL
~1.8	NULL
ng	NULL
;	NULL
6-fold	NULL
the	NULL
molar	NULL
amount	NULL
of	NULL
p58	NULL
;	NULL
27	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
conjugation	NULL
reactions	NULL
involving	NULL
p53	NULL
.	NULL

Lane	NULL
A	NULL
,	NULL
labeled	NULL
substrate	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
£1	NULL
B	NULL
and	NULL
E2	NULL
alone	NULL
.	NULL

Lane	NULL
B	NULL
,	NULL
as	NULL
lane	NULL
A	NULL
,	NULL
but	NULL
with	NULL
added	NULL
Fraction	NULL
IIA	NULL
(	NULL
7.5	NULL
ug	NULL
)	NULL
.	NULL

Numbers	NULL
denote	NULL
fraction	NULL
numbers	NULL
.	NULL

Arrows	NULL
indicate	NULL
molecular	NULL
mass	NULL
of	NULL
peak	NULL
fractions	NULL
as	NULL
determined	NULL
by	NULL
calibration	NULL
of	NULL
the	NULL
column	NULL
with	NULL
a	NULL
set	NULL
of	NULL
molecular	NULL
mass	NULL
standards	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

ConJ	NULL
.	NULL

denotes	NULL
ubiquitin	NULL
conjugates	NULL
.	NULL

Notes	NULL
and	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Con	NULL
]	NULL
.	NULL

i	NULL
:	NULL
p53	NULL
4m	NULL
A	NULL
19	NULL
20	NULL
21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
260	NULL
27	NULL
28	NULL
29	NULL
30	NULL
B	NULL
-	NULL
Ori	NULL
.	NULL

N	NULL
a	NULL
|	NULL
|	NULL
C	NULL
hs	NULL
kDa	NULL
(	NULL
-	NULL
97.4	NULL
~120	NULL
kDa	NULL
A	NULL
B	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
29	NULL
30	NULL
31	NULL
32	NULL
33	NULL
-Orl	NULL
.	NULL

kDa	NULL
|-	NULL
97.4	NULL
-69.0	NULL
--	NULL
46.0	NULL
mass	NULL
of	NULL
~100	NULL
kDa	NULL
,	NULL
migrates	NULL
in	NULL
the	NULL
gel	NULL
filtration	NULL
column	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
as	NULL
a	NULL
~120-kDa	NULL
protein	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
the	NULL
slight	NULL
``	NULL
deviation	NULL
``	NULL
from	NULL
the	NULL
authentic	NULL
molecular	NULL
mass	NULL
is	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
ATP-independent	NULL
protease	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
~80	NULL
kDa	NULL
that	NULL
digests	NULL
both	NULL
the	NULL
substrate	NULL
and	NULL
conjugates	NULL
(	NULL
see	NULL
for	NULL
example	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
30	NULL
)	NULL
.	NULL

The	NULL
disappearance	NULL
of	NULL
the	NULL
labeled	NULL
products	NULL
leads	NULL
to	NULL
a	NULL
slight	NULL
deviation	NULL
in	NULL
the	NULL
calculation	NULL
of	NULL
the	NULL
molecular	NULL
mass	NULL
of	NULL
EG-AP	NULL
under	NULL
the	NULL
conditions	NULL
employed	NULL
.	NULL

It	NULL
is	NULL
clear	NULL
,	NULL
however	NULL
,	NULL
that	NULL
the	NULL
two	NULL
ligases	NULL
are	NULL
distinct	NULL
enzymes	NULL
:	NULL
the	NULL
p105	NULL
conjugating	NULL
activity	NULL
peaks	NULL
in	NULL
Fraction	NULL
24	NULL
,	NULL
whereas	NULL
E6-AP	NULL
peaks	NULL
at	NULL
Fraction	NULL
29	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
the	NULL
novel	NULL
ligase	NULL
is	NULL
also	NULL
distinct	NULL
from	NULL
E3	NULL
«	NULL
,	NULL
the	NULL
N-end	NULL
rule	NULL
ligase	NULL
.	NULL

Addition	NULL
of	NULL
£3a	NULL
to	NULL
either	NULL
£2-14	NULL
kDa	NULL
or	NULL
E2-F1	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
conjugates	NULL
(	NULL
Zanes	NULL
A3	NULL
and	NULL
A4	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
£3	NULL
«	NULL
promotes	NULL
conjugation	NULL
of	NULL
lysozyme	NULL
,	NULL
a	NULL
bona	NULL
fide	NULL
N-end	NULL
rule	NULL
substrate	NULL
,	NULL
when	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
E1	NULL
and	NULL
E2-14	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
panel	NULL
B	NULL
)	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
novel	NULL
E3	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
possibility	NULL
that	NULL
,	NULL
like	NULL
EG6-AP	NULL
(	NULL
41	NULL
)	NULL
,	NULL
it	NULL
also	NULL
contains	NULL
an	NULL
active	NULL
-SH	NULL
group	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
enzyme	NULL
is	NULL
inhibited	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
alkylating	NULL
agents	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
since	NULL
we	NULL
did	NULL
not	NULL
use	NULL
a	NULL
purified	NULL
enzyme	NULL
,	NULL
the	NULL
possibility	NULL
always	NULL
exists	NULL
that	NULL
the	NULL
sensitive	NULL
protein	NULL
is	NULL
not	NULL
the	NULL
ligase	NULL
,	NULL
but	NULL
a	NULL
factor	NULL
that	NULL
is	NULL
necessary	NULL
for	NULL
its	NULL
activity	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
the	NULL
fractions	NULL
that	NULL
contain	NULL
the	NULL
ligase	NULL
activity	NULL
represent	NULL
an	NULL
overlapping	NULL
region	NULL
between	NULL
the	NULL
ligase	NULL
and	NULL
the	NULL
putative	NULL
factor	NULL
.	NULL

If	NULL
this	NULL
is	NULL
indeed	NULL
the	NULL
case	NULL
,	NULL
it	NULL
is	NULL
expected	NULL
that	NULL
combination	NULL
of	NULL
aliquots	NULL
from	NULL
the	NULL
margins	NULL
of	NULL
the	NULL
peak	NULL
(	NULL
that	NULL
represent	NULL
the	NULL
individual	NULL
peaks	NULL
of	NULL
the	NULL
ligase	NULL
and	NULL
the	NULL
factor	NULL
)	NULL
should	NULL
give	NULL
a	NULL
synergistic	NULL
effect	NULL
in	NULL
conjugate	NULL
formation	NULL
.	NULL

This	NULL
is	NULL
clearly	NULL
not	NULL
the	NULL
case	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
alkylating	NULL
agents	NULL
affected	NULL
the	NULL
£3	NULL
directly	NULL
.	NULL

The	NULL
20	NULL
S	NULL
Proteasome	NULL
Is	NULL
Involved	NULL
in	NULL
Processing	NULL
of	NULL
p105-The	NULL
20	NULL
S	NULL
proteasome	NULL
complex	NULL
is	NULL
the	NULL
core	NULL
catalytic	NULL
subunit	NULL
of	NULL
the	NULL
26	NULL
S	NULL
proteasome	NULL
complex	NULL
involved	NULL
in	NULL
degradation	NULL
of	NULL
ubiquitin-tagged	NULL
proteins	NULL
and	NULL
recycling	NULL
of	NULL
ubiquitin	NULL
.	NULL

The	NULL
20	NULL
S	NULL
enzyme	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
C-terminal	NULL
aldehyde	NULL
deriva-	NULL
tives	NULL
of	NULL
short	NULL
peptides	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
agents	NULL
inhibit	NULL
degradation	NULL
of	NULL
substrates	NULL
of	NULL
the	NULL
ubiquitin	NULL
system	NULL
(	NULL
see	NULL
for	NULL
example	NULL
Refs	NULL
.	NULL

12	NULL
,	NULL
20	NULL
,	NULL
and	NULL
42	NULL
)	NULL
but	NULL
potentially	NULL
also	NULL
that	NULL
of	NULL
substrates	NULL
that	NULL
are	NULL
degraded	NULL
by	NULL
the	NULL
26	NULL
S	NULL
proteasome	NULL
in	NULL
a	NULL
ubiquitin-independ-ent	NULL
manner	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

11	NULL
,	NULL
addition	NULL
of	NULL
MG115	NULL
(	NULL
12	NULL
,	NULL
42	NULL
)	NULL
leads	NULL
to	NULL
inhibition	NULL
of	NULL
processing	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
the	NULL
20	NULL
S	NULL
proteasome	NULL
,	NULL
most	NULL
probably	NULL
as	NULL
part	NULL
of	NULL
the	NULL
26	NULL
S	NULL
complex	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
processing	NULL
of	NULL
p105	NULL
in	NULL
vitro	NULL
.	NULL

Using	NULL
a	NULL
similar	NULL
inhibitor	NULL
,	NULL
Palombella	NULL
and	NULL
colleagues	NULL
described	NULL
similar	NULL
results	NULL
for	NULL
processing	NULL
of	NULL
p105	NULL
in	NULL
vivo	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
involved	NULL
in	NULL
processing	NULL
of	NULL
intact	NULL
p105	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
Palombella	NULL
and	NULL
colleagues	NULL
(	NULL
12	NULL
)	NULL
utilized	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
p105	NULL
,	NULL
p60	NULL
,	NULL
to	NULL
demonstrate	NULL
the	NULL
involvement	NULL
of	NULL
ubiquitin	NULL
in	NULL
processing	NULL
.	NULL

They	NULL
have	NULL
not	NULL
demonstrated	NULL
,	NULL
however	NULL
,	NULL
formation	NULL
of	NULL
conjugates	NULL
as	NULL
essential	NULL
intermediates	NULL
in	NULL
the	NULL
process	NULL
.	NULL

While	NULL
analysis	NULL
of	NULL
mutant/truncated	NULL
proteins	NULL
can	NULL
be	NULL
powerful	NULL
,	NULL
one	NULL
should	NULL
be	NULL
cautious	NULL
.	NULL

The	NULL
ubiquitin	NULL
system	NULL
may	NULL
recognize	NULL
abnor-mal/truncated/misfolded	NULL
proteins	NULL
,	NULL
but	NULL
not	NULL
their	NULL
normal	NULL
coun-terparts	NULL
.	NULL

For	NULL
example	NULL
,	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
E1A	NULL
adenovirus	NULL
protein	NULL
(	NULL
amino	NULL
acid	NULL
residues	NULL
1-85	NULL
)	NULL
is	NULL
much	NULL
more	NULL
sensitive	NULL
to	NULL
degradation	NULL
then	NULL
the	NULL
wild	NULL
type	NULL
(	NULL
1-289	NULL
)	NULL
protein	NULL
(	NULL
29	NULL
,	NULL
43	NULL
)	NULL
.	NULL

The	NULL
case	NULL
of	NULL
p53	NULL
is	NULL
even	NULL
more	NULL
illustrative	NULL
,	NULL
although	NULL
the	NULL
direction	NULL
appears	NULL
to	NULL
be	NULL
``	NULL
opposite	NULL
.	NULL
``	NULL

A	NULL
single	NULL
mutation	NULL
can	NULL
render	NULL
the	NULL
wild	NULL
type	NULL
protein	NULL
resistant	NULL
to	NULL
conjugation	NULL
and	NULL
degradation	NULL
because	NULL
of	NULL
a	NULL
significant	NULL
crucial	NULL
alteration	NULL
in	NULL
the	NULL
three-dimensional	NULL
structure	NULL
(	NULL
27	NULL
,	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Processing	NULL
of	NULL
p105	NULL
to	NULL
p50	NULL
occurs	NULL
post-translationally	NULL
.	NULL

It	NULL
requires	NULL
ATP	NULL
and	NULL
occurs	NULL
in	NULL
a	NULL
time-dependent	NULL
manner	NULL
.	NULL

The	NULL
process	NULL
occurs	NULL
only	NULL
in	NULL
mammalian	NULL
cell	NULL
extracts	NULL
and	NULL
not	NULL
in	NULL
plant	NULL
.	NULL

Our	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
plant	NULL
extract	NULL
,	NULL
most	NULL
probably	NULL
,	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
required	NULL
ubiquitin-protein	NULL
ligase	NULL
,	NULL
£3	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Further	NULL
investigation	NULL
revealed	NULL
that	NULL
conjugation	NULL
of	NULL
ubiquitin	NULL
precedes	NULL
processing	NULL
and	NULL
is	NULL
an	NULL
essential	NULL
intermediate	NULL
step	NULL
in	NULL
the	NULL
process	NULL
;	NULL
MeUb	NULL
inhibits	NULL
both	NULL
processes	NULL
,	NULL
and	NULL
the	NULL
inhibition	NULL
is	NULL
alleviated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
NF-kB	NULL
Precursor	NULL
Processing	NULL
by	NULL
the	NULL
Ubiquitin	NULL
System	NULL
|1234|	NULL
Con|j	NULL
.	NULL

kDa	NULL
yl	NULL
vics	NULL
=|	NULL
bli	NULL
h	NULL
t	NULL
|	NULL
21713	NULL
-	NULL
Ori	NULL
.	NULL

|	NULL
kDa	NULL
[	NULL
-	NULL
97.4	NULL
Coni_	NULL
~	NULL
»	NULL
-	NULL
69.0	NULL
«	NULL
hte	NULL
-	NULL
46.0	NULL
f-	NULL
30.0	NULL
**	NULL
¢	NULL
.	NULL

Lyz0	NULL
.	NULL

-z	NULL
-	NULL
14.3	NULL
D.F	NULL
.	NULL

Fic	NULL
.	NULL

9	NULL
.	NULL

Ubiquitin-p105	NULL
ligase	NULL
is	NULL
a	NULL
novel	NULL
species	NULL
of	NULL
£3	NULL
distinct	NULL
from	NULL
ESa	NULL
.	NULL

Ubiquitin	NULL
conjugates	NULL
of	NULL
p105	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
and	NULL
'*	NULL
``	NULL
I-labeled	NULL
lysozyme	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
were	NULL
generated	NULL
essentially	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
experiment	NULL
described	NULL
in	NULL
pane	NULL
!	NULL

A	NULL
was	NULL
analyzed	NULL
by	NULL
PhosphorImager	NULL
.	NULL

Lane	NULL
A1	NULL
,	NULL
incubation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
£1	NULL
and	NULL
E2-F1	NULL
.	NULL

Lane	NULL
A2	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
A1	NULL
,	NULL
but	NULL
with	NULL
Fraction	NULL
IIA	NULL
(	NULL
7.5	NULL
ug	NULL
)	NULL
.	NULL

Lane	NULL
A3	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
A1	NULL
,	NULL
but	NULL
with	NULL
E8a	NULL
(	NULL
0.6	NULL
microunit	NULL
;	NULL
1	NULL
unit	NULL
of	NULL
enzyme	NULL
catalyzes	NULL
the	NULL
incorporation	NULL
of	NULL
ubiquitin	NULL
into	NULL
conjugates	NULL
at	NULL
a	NULL
rate	NULL
of	NULL
1	NULL
umol/min	NULL
;	NULL
Ref	NULL
.	NULL

31	NULL
)	NULL
.	NULL

Lane	NULL
A4	NULL
,	NULL
reaction	NULL
mixture	NULL
contained	NULL
E1	NULL
,	NULL
£2-14	NULL
kDa	NULL
(	NULL
0.15	NULL
ug	NULL
)	NULL
,	NULL
and	NULL
E8	NULL
@	NULL
.	NULL

Lane	NULL
B1	NULL
,	NULL
with	NULL
E1	NULL
and	NULL
E2-14	NULL
kDa	NULL
.	NULL

Lane	NULL
B2	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
B1	NULL
,	NULL
but	NULL
with	NULL
ESa	NULL
.	NULL

E1	NULL
,	NULL
and	NULL
E2-F1	NULL
were	NULL
added	NULL
in	NULL
the	NULL
same	NULL
amounts	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Con	NULL
;	NULL
.	NULL

denote	NULL
ubiquitin	NULL
conjugates	NULL
.	NULL

Notes	NULL
and	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
|	NULL
--	NULL
Ori	NULL
.	NULL

Con|j	NULL
.	NULL

kDa	NULL
p105	NULL
_	NULL
-	NULL
|-	NULL
ara	NULL
Fic	NULL
.	NULL

10	NULL
.	NULL

The	NULL
ubiquitin-p105	NULL
ligase	NULL
has	NULL
an	NULL
active-SH	NULL
group	NULL
.	NULL

Conjugation	NULL
of	NULL
ubiquitin	NULL
to	NULL
p105	NULL
was	NULL
monitored	NULL
essentially	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

All	NULL
reaction	NULL
mixtures	NULL
contained	NULL
E1	NULL
,	NULL
E2-F1	NULL
,	NULL
and	NULL
C3.F6	NULL
cytosolic	NULL
extract	NULL
as	NULL
a	NULL
source	NULL
for	NULL
£3	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
the	NULL
enzymes	NULL
added	NULL
are	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
and	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
complete	NULL
reaction	NULL
mixture	NULL
containing	NULL
all	NULL
three	NULL
conjugating	NULL
enzymes	NULL
,	NULL
but	NULL
without	NULL
ATP	NULL
.	NULL

Lane	NULL
2	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
,	NULL
but	NULL
with	NULL
ATP	NULL
.	NULL

Lane	NULL
3	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
2	NULL
,	NULL
but	NULL
the	NULL
cytosolic	NULL
extract	NULL
was	NULL
treated	NULL
first	NULL
with	NULL
sodium	NULL
iodoacetate	NULL
and	NULL
neutralized	NULL
with	NULL
DTT	NULL
.	NULL

Lane	NULL
4	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
2	NULL
,	NULL
but	NULL
the	NULL
extract	NULL
was	NULL
treated	NULL
first	NULL
with	NULL
NEM	NULL
and	NULL
neutralized	NULL
with	NULL
DTT	NULL
.	NULL

Lane	NULL
5	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
2	NULL
,	NULL
but	NULL
the	NULL
extract	NULL
was	NULL
treated	NULL
first	NULL
with	NULL
p-hydroxymercuribenzoate	NULL
and	NULL
neutralized	NULL
with	NULL
DTT	NULL
.	NULL

Lane	NULL
6	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
2	NULL
,	NULL
but	NULL
NEM	NULL
was	NULL
added	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
DTT	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
the	NULL
inhibitor	NULL
was	NULL
added	NULL
at	NULL
10	NULL
mM	NULL
and	NULL
the	NULL
extract	NULL
incubated	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

DTT	NULL
was	NULL
then	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
6	NULL
mM	NULL
.	NULL

Con	NULL
.	NULL

denotes	NULL
ubiquitin	NULL
conjugates	NULL
.	NULL

Notes	NULL
and	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1.	NULL
excess	NULL
free	NULL
ubiquitin	NULL
.	NULL

To	NULL
study	NULL
the	NULL
conjugating	NULL
enzymes	NULL
in-volved	NULL
,	NULL
we	NULL
reconstituted	NULL
a	NULL
cell-free	NULL
system	NULL
and	NULL
demonstrated	NULL
that	NULL
E2-F1	NULL
,	NULL
a	NULL
recently	NULL
characterized	NULL
ubiquitin-carrier	NULL
protein	NULL
isolated	NULL
from	NULL
crude	NULL
reticulocyte	NULL
Fraction	NULL
I	NULL
(	NULL
26	NULL
)	NULL
,	NULL
is	NULL
required	NULL
for	NULL
the	NULL
process	NULL
.	NULL

We	NULL
have	NULL
also	NULL
demonstrated	NULL
that	NULL
the	NULL
human	NULL
homolog	NULL
of	NULL
£E2-F1	NULL
,	NULL
(	NULL
830	NULL
)	NULL
,	NULL
also	NULL
catalyzes	NULL
conjugation	NULL
of	NULL
p105	NULL
.	NULL

Interestingly	NULL
,	NULL
E2-F1	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
conjugation	NULL
and	NULL
degradation	NULL
of	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
26	NULL
)	NULL
,	NULL
p53	NULL
(	NULL
27	NULL
)	NULL
,	NULL
and	NULL
c-Fos	NULL
,	NULL
``	NULL
and	NULL
therefore	NULL
,	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
specific	NULL
.	NULL

However	NULL
,	NULL
another	NULL
species	NULL
of	NULL
ubiquitin-carrier	NULL
protein	NULL
,	NULL
E2-14	NULL
kDa	NULL
,	NULL
is	NULL
not	NULL
able	NULL
to	NULL
promote	NULL
conjugation	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
a	NULL
novel	NULL
,	NULL
still	NULL
unidentified	NULL
,	NULL
species	NULL
of	NULL
£3	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
process	NULL
.	NULL

This	NULL
ligase	NULL
,	NULL
which	NULL
is	NULL
not	NULL
present	NULL
in	NULL
wheat	NULL
germ	NULL
,	NULL
is	NULL
distinct	NULL
from	NULL
E6-AP	NULL
,	NULL
the	NULL
ligase	NULL
involved	NULL
in	NULL
E6-dependent	NULL
tagging	NULL
of	NULL
p53	NULL
(	NULL
37	NULL
)	NULL
,	NULL
and	NULL
from	NULL
E3a	NULL
,	NULL
the	NULL
``	NULL
N-end	NULL
rule	NULL
``	NULL
ligase	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
E2-F1	NULL
can	NULL
act	NULL
in	NULL
concert	NULL
with	NULL
several	NULL
species	NULL
of	NULL
£3	NULL
s	NULL
,	NULL
and	NULL
the	NULL
£3	NULL
enzymes	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
specific	NULL
recognition	NULL
of	NULL
the	NULL
substrates	NULL
.	NULL

The	NULL
novel	NULL
£3	NULL
appears	NULL
to	NULL
contain	NULL
an	NULL
-SH	NULL
group	NULL
essential	NULL
for	NULL
its	NULL
activity	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
processing	NULL
is	NULL
in	NULL
*I.	NULL
Stancovski	NULL
and	NULL
A.	NULL
Ciechanover	NULL
,	NULL
unpublished	NULL
results	NULL
.	NULL

MG115	NULL
=	NULL
+	NULL
kDa	NULL
p105	NULL
-_	NULL
--	NULL
-	NULL
97.4	NULL
wll	NULL
--	NULL
69.0	NULL
p50	NULL
-	NULL
--	NULL
]	NULL
ww	NULL
-	NULL
46.0	NULL
Fig	NULL
.	NULL

11	NULL
.	NULL

Inhibition	NULL
of	NULL
the	NULL
20	NULL
S	NULL
proteasome	NULL
suppresses	NULL
processing	NULL
of	NULL
p105	NULL
.	NULL

Processing	NULL
of	NULL
p105	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
reticulocyte	NULL
lysate	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
50	NULL
uM	NULL
MG115	NULL
,	NULL
a	NULL
20	NULL
S	NULL
proteasome	NULL
inhibitor	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Notes	NULL
and	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1.	NULL
hibited	NULL
by	NULL
inhibitors	NULL
of	NULL
the	NULL
20	NULL
S	NULL
proteasome	NULL
complex	NULL
.	NULL

An	NULL
important	NULL
problem	NULL
involves	NULL
the	NULL
mechanism	NULL
of	NULL
processing	NULL
.	NULL

Unlike	NULL
all	NULL
other	NULL
substrates	NULL
of	NULL
the	NULL
ubiquitin	NULL
system	NULL
,	NULL
p105	NULL
is	NULL
only	NULL
partially	NULL
degraded	NULL
.	NULL

It	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
the	NULL
C-terminal	NULL
domain	NULL
is	NULL
first	NULL
cleaved	NULL
and	NULL
then	NULL
degraded	NULL
,	NULL
or	NULL
whether	NULL
digestion	NULL
starts	NULL
in	NULL
the	NULL
C-terminal	NULL
residue	NULL
of	NULL
p105	NULL
and	NULL
stops	NULL
at	NULL
certain	NULL
point	NULL
.	NULL

The	NULL
cleavage	NULL
site	NULL
,	NULL
or	NULL
the	NULL
``	NULL
stop	NULL
``	NULL
signal	NULL
,	NULL
has	NULL
not	NULL
been	NULL
identified	NULL
,	NULL
although	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
it	NULL
may	NULL
reside	NULL
in	NULL
the	NULL
region	NULL
of	NULL
amino	NULL
acid	NULL
residue	NULL
420	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Another	NULL
problem	NULL
concerns	NULL
regulation	NULL
of	NULL
processing	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
stimulation-induced	NULL
phosphorylation	NULL
of	NULL
the	NULL
precursor	NULL
may	NULL
accelerate	NULL
its	NULL
processing	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
activation	NULL
of	NULL
one	NULL
or	NULL
more	NULL
specific	NULL
components	NULL
of	NULL
the	NULL
ubiquitin	NULL
system	NULL
occurs	NULL
following	NULL
stimulation	NULL
.	NULL

Interestingly	NULL
,	NULL
phosphorylation	NULL
of	NULL
the	NULL
inhibitor	NULL
IxBa	NULL
leads	NULL
to	NULL
its	NULL
rapid	NULL
degradation	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

This	NULL
process	NULL
also	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
ubiquitin	NULL
system	NULL
and	NULL
to	NULL
involve	NULL
E2-F1	NULL
.	NULL
'	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
reconstitution	NULL
of	NULL
the	NULL
cell-free	NULL
proteolytic	NULL
system	NULL
and	NULL
identification	NULL
of	NULL
the	NULL
enzymes	NULL
involved	NULL
are	NULL
essential	NULL
for	NULL
further	NULL
understanding	NULL
of	NULL
the	NULL
mechanisms	NULL
of	NULL
recognition	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
components	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
complex	NULL
by	NULL
the	NULL
proteolytic	NULL
system	NULL
.	NULL

Acknowledgments-We	NULL
acknowledge	NULL
Drs	NULL
.	NULL

Ross	NULL
Stein	NULL
and	NULL
Julian	NULL
Adams	NULL
(	NULL
MyoGenics	NULL
,	NULL
Inc.	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
the	NULL
20	NULL
S	NULL
proteasome	NULL
inhibitor	NULL
,	NULL
MG115	NULL
,	NULL
and	NULL
Dr.	NULL
Martin	NULL
Scheffner	NULL
(	NULL
DKFZ	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
the	NULL
UbeHS5	NULL
clone	NULL
.	NULL

We	NULL
are	NULL
also	NULL
grateful	NULL
for	NULL
the	NULL
generous	NULL
help	NULL
and	NULL
advice	NULL
of	NULL
Dr.	NULL
Hedva	NULL
Gonen	NULL
(	NULL
Technion	NULL
,	NULL
Haifa	NULL
,	NULL
Israel	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
21714	NULL
go	NULL
bo	NULL
ia	NULL
g	NULL
ous	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28	NULL
.	NULL

REFERENCES	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
705-716	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Henkel	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
,	NULL
141-179	NULL
.	NULL

Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Brown	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10	NULL
,	NULL
405-455	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
529-532	NULL
.	NULL

Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

5	NULL
,	NULL
477-487	NULL
.	NULL

Sha	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tuomanen	NULL
,	NULL
E.	NULL
I.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
80	NULL
,	NULL
321-330	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vanderkerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
Duckett	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Andrews	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
852	NULL
,	NULL
733-737	NULL
.	NULL

Fan	NULL
,	NULL
C.-M.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
854	NULL
,	NULL
395-398	NULL
.	NULL

Mellits	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Hay	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
and	NULL
Goodbourn	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21	NULL
,	NULL
5059-5066	NULL
Mercurio	NULL
,	NULL
F.	NULL
,	NULL
DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Rosette	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
705-718	NULL
Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
Rando	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
Goldberg	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
773-785	NULL
Murakami	NULL
,	NULL
Y.	NULL
,	NULL
Matsufuji	NULL
,	NULL
S.	NULL
,	NULL
Kameji	NULL
,	NULL
T.	NULL
,	NULL
Hayashi	NULL
,	NULL
S.	NULL
,	NULL
Igarashi	NULL
,	NULL
K.	NULL
,	NULL
Tamura	NULL
,	NULL
T.	NULL
,	NULL
Tanaka	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ichihara	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nature	NULL
860	NULL
,	NULL
597-599	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
dos	NULL
Santos	NULL
Silva	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
201-211	NULL
Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
Maki	NULL
,	NULL
M.	NULL
,	NULL
Schmitt	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
,	NULL
Hatanaka	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
12740-12744	NULL
Lin	NULL
,	NULL
Y.	NULL
C.	NULL
,	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
552-556	NULL
Didonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Mercurio	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1302-1311	NULL
Alkalay	NULL
,	NULL
I.	NULL
,	NULL
Yaron	NULL
,	NULL
A.	NULL
,	NULL
Hatzubai	NULL
,	NULL
A.	NULL
,	NULL
Jung	NULL
,	NULL
S.	NULL
,	NULL
Avraham	NULL
,	NULL
A.	NULL
,	NULL
Gerlitz	NULL
,	NULL
O.	NULL
,	NULL
Pashut-Lavon	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1294-1301	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
Gerstberger	NULL
,	NULL
S.	NULL
,	NULL
Carlson	NULL
,	NULL
L.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1485-1488	NULL
Traenckner	NULL
,	NULL
E.	NULL
B.-M.	NULL
,	NULL
Wilk	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
5483-5441	NULL
Ciechanover	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cell	NULL
79	NULL
,	NULL
13-21	NULL
Hershko	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Ciechanover	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

61	NULL
,	NULL
761-807	NULL
Jentsch	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Genet	NULL
.	NULL

26	NULL
,	NULL
179-207	NULL
24	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

NF-kB	NULL
Precursor	NULL
Processing	NULL
by	NULL
the	NULL
Ubiquitin	NULL
System	NULL
.	NULL

Michalek	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Grant	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Gramm	NULL
,	NULL
C.	NULL
,	NULL
Goldberg	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Rock	NULL
,	NULL
K.	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
8	NULL
,	NULL
552-554	NULL
Cox	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Galardy	NULL
,	NULL
P.	NULL
,	NULL
Bennink	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Yewdell	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

154	NULL
,	NULL
511-519	NULL
Blumenfeld	NULL
,	NULL
N.	NULL
,	NULL
Gonen	NULL
,	NULL
H.	NULL
,	NULL
Mayer	NULL
,	NULL
A.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
,	NULL
Siegel	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Schwartz	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Ciechanover	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
9574-9581	NULL
Ciechanover	NULL
,	NULL
A.	NULL
,	NULL
Shkedy	NULL
,	NULL
D.	NULL
,	NULL
Oren	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Bercovich	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
9582-9589	NULL
Pollock	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Treisman	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
6197-6204	NULL
Ciechanover	NULL
,	NULL
A.	NULL
,	NULL
DiGiuseppe	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Bercovich	NULL
,	NULL
B.	NULL
,	NULL
Orian	NULL
,	NULL
A.	NULL
,	NULL
Richter	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Schwartz	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Brodeur	NULL
,	NULL
G.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
139-143	NULL
Scheffner	NULL
,	NULL
M.	NULL
,	NULL
Huibregtse	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Howley	NULL
,	NULL
P.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
8797-8801	NULL
Hershko	NULL
,	NULL
A.	NULL
,	NULL
Heller	NULL
,	NULL
H.	NULL
,	NULL
Elias	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Ciechanover	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

258	NULL
,	NULL
8206-8214	NULL
Reiss	NULL
,	NULL
Y.	NULL
,	NULL
Kaim	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Hershko	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
26983-2698	NULL
Ganoth	NULL
,	NULL
D.	NULL
,	NULL
Leshinsky	NULL
,	NULL
E.	NULL
,	NULL
Eytan	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Hershko	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263	NULL
,	NULL
12412-12419	NULL
Flanagan	NULL
,	NULL
W.	NULL
M.	NULL
,	NULL
Corthésy	NULL
,	NULL
B.	NULL
,	NULL
Bram	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
352	NULL
,	NULL
803-807	NULL
Hershko	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Rose	NULL
,	NULL
I	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Nafl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
1829-1833	NULL
Hershko	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Heller	NULL
,	NULL
H.	NULL
(	NULL
1985	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

128	NULL
,	NULL
1079-1086	NULL
Scheffner	NULL
,	NULL
M.	NULL
,	NULL
Huibregtse	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Vierstra	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Howley	NULL
,	NULL
P.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
75	NULL
,	NULL
495-505	NULL
Haas	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Bright	NULL
,	NULL
P.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

260	NULL
,	NULL
12464-12473	NULL
Hershko	NULL
,	NULL
A.	NULL
,	NULL
Ganoth	NULL
,	NULL
D.	NULL
,	NULL
Pehrson	NULL
,	NULL
G.	NULL
,	NULL
Palazzo	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
and	NULL
Cohen	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
16376-16379	NULL
Huibregtse	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Scheffner	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Howley	NULL
,	NULL
P.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
775-784	NULL
Scheffner	NULL
,	NULL
M.	NULL
,	NULL
Nuber	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Huibregtse	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
378	NULL
,	NULL
81-83	NULL
Rock	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Gramm	NULL
,	NULL
C.	NULL
,	NULL
Rothstein	NULL
,	NULL
L.	NULL
,	NULL
Clark	NULL
,	NULL
K.	NULL
,	NULL
Stein	NULL
,	NULL
R.	NULL
,	NULL
Dick	NULL
,	NULL
L.	NULL
,	NULL
Hwang	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Goldberg	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
761-771	NULL
Slaviceck	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Jones	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
and	NULL
Richter	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

7	NULL
,	NULL
3171-3180	NULL
Halevy	NULL
,	NULL
O.	NULL
,	NULL
Michalovitz	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Oren	NULL
,	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
250	NULL
,	NULL
113-116	NULL
Crook	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Vousden	NULL
,	NULL
K.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
3935-3940	NULL
Riviere	NULL
,	NULL
Y.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nature	NULL
850	NULL
,	NULL
625-626	NULL
Naumann	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Scheidereit	NULL
,	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
4597-4607	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Ubiquitin-mediated	NULL
Processing	NULL
of	NULL
NF-xB	NULL
Transcriptional	NULL
Activator	NULL
Precursor	NULL
p105	NULL
:	NULL
RECONSTITUTION	NULL
OF	NULL
A	NULL
CELL-FREE	NULL
SYSTEM	NULL
AND	NULL
IDENTIFICATION	NULL
OF	NULL
THE	NULL
UBIQUITIN-CARRIER	NULL
PROTEIN	NULL
,	NULL
E2	NULL
,	NULL
AND	NULL
A	NULL
NOVEL	NULL
UBIQUITIN-PROTEIN	NULL
LIGASE	NULL
,	NULL
E3	NULL
,	NULL
INVOLVED	NULL
IN	NULL
CONJUGATION	NULL
Amir	NULL
Orian	NULL
,	NULL
Simon	NULL
Whiteside	NULL
,	NULL
Alain	NULL
Israél	NULL
,	NULL
Hana	NULL
Stancovski	NULL
,	NULL
Alan	NULL
L.	NULL
Schwartz	NULL
and	NULL
Aaron	NULL
Ciechanover	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1995	NULL
,	NULL
270:21707-21714.	NULL
doi	NULL
:	NULL
10.1074/jb0.270.37.21707	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/270/37/21707	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
47	NULL
references	NULL
,	NULL
18	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
707	NULL
.full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

